Paper tissue with high bulk and low lint

Information

  • Patent Grant
  • 11591755
  • Patent Number
    11,591,755
  • Date Filed
    Tuesday, November 1, 2016
    7 years ago
  • Date Issued
    Tuesday, February 28, 2023
    a year ago
Abstract
A tissue paper product is provided having at least one ultra-low density ply having a highly porous, open-celled structure and that comprises cellulosic fibers, a water insoluble binder and a foaming surfactant. The cellulosic fiber comprises greater than 50% by weight of the ply and are bonded to one another by hydrogen bonding. Further, the ply has a density less than about 0.04 g/cc and yet still provides low lint and high strength properties with the use of minimal binder. The ultra-low density ply may comprise or be included in sheets forming a stack of dispensable wipers or may be employed as or part of an absorbent core or liquid distribution layer of a personal care absorbent personal care product such as a diaper or feminine pad.
Description
BACKGROUND

Wood pulp fiber is a natural fiber widely used in personal care products such as facial tissue, toilet paper, paper hand towels, cosmetic wipes, etc. Wood pulp fiber is a relatively inexpensive raw material and is widely available. In addition, wood pulp fibers have various advantageous properties such as being highly absorbent, relatively soft and biodegradable. However, these desirable properties are often lost or degraded as a result of the sheet formation process. In this regard, wood pulp fibers have a relatively short fiber length, commonly between about 0.5-2 mm, which makes it difficult to achieve both the desired fiber orientation and structure (i.e. to achieve a high-bulk sheet having good hand and flexibility) and also the desired degree of sheet integrity and fiber retention (i.e. to achieve a stable structure and minimize linting).


Wood pulp fiber is typically incorporated into a sheet by either an air laying or wet laying process. With respect to cellulosic sheets formed by air laying process, sheets formed from such processes tend to have a high bulk as the air-laying processes typically achieve an open and non-oriented fiber structure. However, such air-laid sheets also tend to suffer from low integrity and high lint due to the lack of hydrogen bonding as between the individual fibers. While sheet integrity and linting can be improved through the addition of significant levels of binder fibers or adhesive, the inclusion of the same often causes the sheet to lose desired attributes such as softness, drape and other properties such as biodegradability and/or flushability.


On the other hand, with respect to wood pulp fibers processed by a wet laying process, the resulting sheets often have relatively low lint content due to the extensive hydrogen bonding between wood pulp fibers. However, the wet laid sheets sacrifice bulk and wet integrity due to the generally planar and compact fiber orientation.


Therefore, it would be desirable to have a paper tissue sheet comprising wood pulp or like cellulosic fibers and minimal binder having a combination of advantageous properties such as sheet integrity, high bulk and low lint content.


SUMMARY OF INVENTION

The present invention provides a tissue paper product having at least one ultra-low density ply having a highly porous, open-celled structure and that comprises cellulosic fibers, a water insoluble binder and a foaming surfactant. The cellulosic fiber comprises greater than 50% by weight of the ply and are bonded to one another by hydrogen bonding. Further, the ply has a density less than about 0.04 g/cc and yet still provides a Gelbo Lint Value less than 5 and a wet tensile strength of at least 10 g-f. In certain embodiments, the ply has a substantially planar, sheet-like structure having a thickness of between about 0.5 and about 5 mm. In addition, water insoluble binders, such as binder fibers, comprise less than about 10% of the ply. In certain embodiments, the tissue paper product can further include one or more additional plies, attached to the ultra-low density ply, comprising a wet-laid tissue including at least 95% wood pulp fibers and having a density between about 0.5 and 0.04 g/cc. Further, one or more of the plies may be pattern embossed, either individually or together with other plies.


In one embodiment, the tissue product may be utilized as part of a wiper and included within a packaged wiping product. In this regard, a packaged wipes product is also provided having a container that defines an interior space and that houses a stack of between 3 and 150 individual wipers. The individual wipers within the container include one or more layers of the ultra-low density tissue sheets described herein. In certain embodiments the packaged wiping product can comprise a stack of wipers provided in a roll format having individual wipers separated by lines of perforation or in a superposed format having wipers in an inter-folded relationship. In still a further embodiment, the ultra-low density tissue sheets may be employed as or part of an absorbent core or liquid distribution layer of a personal care absorbent product such as, for example, a diaper, panty-liner and so forth.





FIGURES


FIG. 1 is a perspective view of a dispenser housing a stack of tissue sheets of the present invention.



FIG. 2 is a top, plan view of an absorbent personal care article including an absorbent material of the present invention.





DESCRIPTION

The ultra-low density paper tissue webs of the present invention are made by forming a highly-expanded, highly porous foam from a foam precursor or slurry comprising (i) a foaming fluid; (ii) cellulosic fibers; (iii) foaming surfactant and, optionally one or more (iv) binders; (v) foam stabilizers; (vi) strength enhancing agents; or (vii) additional additives.


Foaming Fluid


Any one or more known foaming fluids compatible with the other components may be used in the practice of the present invention. Suitable foaming fluids include, but are not limited to, water and so forth. The foaming fluid can comprise between about 90% and about 99.9% % of the slurry. In certain embodiments the foaming fluid can comprise between about 93% and 99.5% of the slurry or even between about 95% and about 99.0% of the slurry.


Cellulosic Fibers


A wide variety of cellulosic fibers are believed suitable for use herein. The ultra-low density cellulosic webs of the present invention can, in one aspect, comprise conventional papermaking fibers such as wood pulp fibers formed by a variety of pulping processes, such as kraft pulp, sulfite pulp, bleached chemithermomechanical pulp (BCTMP), chemithermomechanical pulp (CTMP), pressure/pressure thermomechanical pulp (PIMP), thermomechanical pulp (TMP), thermomechanical chemical pulp (TMCP), and so forth. By way of example only, fibers and methods of making wood pulp fibers are disclosed in U.S. Pat. No. 4,793,898 to Laamanen et al.; U.S. Pat. No. 4,594,130 to Chang et al.; U.S. Pat. No. 3,585,104 to Kleinhart; U.S. Pat. No. 5,595,628 to Gordon et al.; U.S. Pat. No. 5,522,967 to Shet; and so forth. Further, the fibers may be any high-average fiber length wood pulp, low-average fiber length wood pulp, or mixtures of the same. Examples of suitable high-average length pulp fibers include softwood fibers, such as, but not limited to, northern softwood, southern softwood, redwood, red cedar, hemlock, pine (e.g., southern pines), spruce (e.g., black spruce), combinations thereof, and the like. Examples of suitable low-average length pulp fibers include hardwood fibers, such as, but not limited to, eucalyptus, maple, birch, aspen, and the like.


Moreover, if desired, secondary fibers obtained from recycled materials may be used, such as fiber pulp from sources such as, for example, newsprint, reclaimed paperboard, and office waste. In a particularly preferred embodiment refined fibers are utilized in the tissue web such that the total amount of virgin and/or high average fiber length wood fibers, such as softwood fibers, may be reduced.


Regardless of the origin of the wood pulp fiber, the wood pulp fibers preferably have an average fiber length greater than about 0.2 mm and less than about 3 mm, such as from about 0.35 mm and about 2.5 mm, or between about 0.5 mm to about 2 mm or even between about 0.7 mm and about 1.5 mm.


In addition, other cellulosic fibers believed suitable for use in making the cellulosic webs of the present invention include nonwoody fibers, such as cotton, abaca, bambo, kenaf, sabai grass, flax, esparto grass, straw, jute hemp, bagasse, milkweed floss fibers, and pineapple leaf fibers. In addition other cellulosic fibers for making the tissue webs include synthetic cellulose fiber types including rayon in all its varieties and other fibers derived from viscose or chemically-modified cellulose such as, for example, those available under the trade names LYOCELL and TENCEL. The non-woody and synthetic cellulosic fibers can have fiber length greater than about 0.2 mm including, for example, having an average fiber size between about 0.5 mm and about 50 mm or between about 0.75 and about 30 mm or even between about 1 mm and about 25 mm. Generally speaking, when fibers of relatively larger average length are being used, it will often be advantageous to utilize relatively higher amounts of foaming surfactant in order to help achieve a foam with the required stability.


The solids content, including the cellulosic fibers and any other fibers or particulates contained herein, desirably comprise no more than about 15% of the slurry. In certain embodiments the cellulosic fibers can comprise between about 0.1% and about 15% of the slurry or between about 0.2 and about 10% of the slurry or even between about 0.5% and about 8% of the slurry.


Foaming Surfactant


The ultra-low density paper tissue webs of the present invention are made utilizing one of more surfactants capable of forming a stable, high-expansion foam. The fibers and surfactant, together with the foaming liquid and any additional components, need to form a stable dispersion capable of substantially retaining a high degree of porosity for longer that the drying process. In this regard, the surfactant is selected so as to provide a foam slurry having a stability of at least 15 minutes, and still more desirably at least 30 minutes. The foaming surfactant used in the slurry can be selected from one or more known in the art that are capable of providing the desired degree of foam stability. In this regard, the foaming surfactant can be selected from anionic, cationic, nonionic and amphoteric surfactants provided they, alone or in combination with other components, provide the necessary foam stability. As will be appreciated, more than one surfactant can be used, including both different types of surfactants and more than one surfactant of the same type.


Anionic surfactants believed suitable for use with the present invention include, without limitation, anionic sulfate surfactants, alkyl ether sulfonates, alkylaryl sulfonates, or mixtures or combinations thereof. Examples of alkylaryl sulfonates include, without limitation, alkyl benzene sulfonic acids and their salts, dialkylbenzene disulfonic acids and their salts, dialkylbenzene sulfonic acids and their salts, alkylphenol sulfonic acids/condensed alkylphenol sulfonic acids and their salts, or mixture or combinations thereof. Examples of additional anionic surfactants believed suitable for use in the present invention include alkali metal sulforicinates, sulfonated glyceryl esters of fatty acids such as sulfonated monoglycerides of coconut oil acids, salts of sulfonated monovalent alcohol esters such as sodium oleylisethianate, metal soaps of fatty acids, amides of amino sulfonic acids such as the sodium salt of oleyl methyl tauride, sulfonated products of fatty acids nitriles such as palmitonitrile sulfonate, alkali metal alkyl sulfates such as sodium lauryl sulfate, ammonium lauryl sulfate or triethanolamine lauryl sulfate, ether sulfates having alkyl groups of 8 or more carbon atoms such as sodium lauryl ether sulfate, ammonium lauryl ether sulfate, sodium alkyl aryl ether sulfates, and ammonium alkyl aryl ether sulfates, sulphuric esters of polyoxyethylene alkyl ether, sodium salts, potassium salts, and amine salts of alkylnapthylsulfonic acid. Certain phosphate including phosphate esters such as sodium lauryl phosphate esters or those available from the Dow Chemical Company under the tradename TRITON are also believed suitable for use herewith. A particularly effective anionic surfactant is sodium dodecyl sulfate (SDS).


Cationic surfactants are also believed suitable for use with the present invention. Foaming cationic surfactants include, without limitation, monocarbyl ammonium salts, dicarbyl ammonium salts, tricarbyl ammonium salts, monocarbyl phosphonium salts, dicarbyl phosphonium salts, tricarbyl phosphonium salts, carbylcarboxy salts, quaternary ammonium salts, imidazolines, ethoxylated amines, quaternary phospholipids and so forth. Examples of additional cationic surfactants include various fatty acid amines and amides and their derivatives, and the salts of the fatty acid amines and amides. Examples of aliphatic fatty acid amines include dodecylamine acetate, octadecylamine acetate, and acetates of the amines of tallow fatty acids, homologues of aromatic amines having fatty acids such as dodecylanalin, fatty amides derived from aliphatic diamines such as undecylimidazoline, fatty amides derived from aliphatic diamines such as undecylimidazoline, fatty amides derived from disubstituted amines such as oleylaminodiethylamine, derivatives of ethylene diamine, quaternary ammonium compounds and their salts which are exemplified by tallow trimethyl ammonium chloride, dioctadecyldimethyl ammonium chloride, didodecyldimethyl ammonium chloride, dihexadecyl ammonium chloride, alkyltrimethylammonium hydroxides, dioctadecyldimethylammonium hydroxide, tallow trimethylammonium hydroxide, trimethylammonium hydroxide, methylpolyoxyethylene cocoammonium chloride, and dipalmityl hydroxyethylammonium methosulfate, amide derivatives of amino alcohols such as beta-hydroxylethylstearylamide, and amine salts of long chain fatty acids. Further examples of cationic surfactants believed suitable for use with the present invention include benzalkonium chloride, benzethonium chloride, cetrimonium bromide, distearyldimethylammonium chloride, tetramethylammonium hydroxide, and so forth.


Nonionic surfactants believed suitable for use in the present invention include, without limitation, condensates of ethylene oxide with a long chain fatty alcohol or fatty acid, condensates of ethylene oxide with an amine or an amide, condensation products of ethylene and propylene oxides, fatty acid alkylol amide and fatty amine oxides. Various examples of non-ionic surfactants include stearyl alcohol, sorbitan monostearate, octyl glucoside, octaethylene glycol monododecyl ether, lauryl glucoside, cetyl alcohol, cocamide MEA, monolaurin, polyoxyalkylene alkyl ethers such as polyethylene glycol long chain (12-14C) alkyl ether, polyoxyalkylene sorbitan ethers, polyoxyalkylene alkoxylate esters, polyoxyalkylene alkylphenol ethers, ethylene glycol propylene glycol copolymers, polyvinyl alcohol, alkylpolysaccharides, polyethylene glycol sorbitan monooleate, octylphenol ethylene oxide, and so forth.


The foaming surfactant can be used in varying amounts as necessary to achieve the desired foam stability and air-content. In certain embodiments, the foaming surfactant can comprise between about 0.01% and about 5% of the slurry. In certain embodiments the foaming surfactant can comprise between about 0.05% and about 3% of the slurry or even between about 0.1% and about 2% of the slurry.


Foam Stabilizers


The foam pre-cursor or slurry may optionally also include one or more foam stabilizers known in the art and that are compatible with the components of the slurry and further do not interfere with the hydrogen bonding as between the cellulosic fibers. Foam stabilizing agents believed suitable for use in the present invention, without limitation, one or more zwitterionic compounds, amine oxides, alkylated polyalkylene oxides, or mixture or combinations thereof. Specific examples of foam stabilizers includes, without limitation, cocoamine oxide, isononyldimethylamine oxide, n-dodecyldimethylamine oxide, and so forth. The foam stabilizer can comprise between about 0.01% and about 2% of the slurry. In certain embodiments the foam stabilizer can comprise between about 0.05% and 1% of the slurry or even between about 0.1 and about 0.5% of the slurry.


Binder


Binder materials include suitable for use in the present invention include, but are not limited to, thermoplastic binder fibers and water-compatible adhesives such as, for example, latexes. Importantly, the binder will comprise one that is water insoluble on the dried cellulosic web. In certain embodiments, latexes used in the present invention can be cationic or anionic to facilitate application to and adherence to the cellulosic fiber. For instance, latexes believed suitable for use with the present invention include, but are not limited to, anionic styrene-butadiene copolymers, polyvinyl acetate homopolymers, vinyl-acetate ethylene copolymers, vinyl-acetate acrylic copolymers, ethylene-vinyl chloride copolymers, ethylene-vinyl chloride-vinyl acetate terpolymers, acrylic polyvinyl chloride polymers, acrylic polymers, nitrile polymers, as well as other suitable anionic latex polymers known in the art. Examples of such latexes are described in U.S. Pat. No. 4,785,030 to Hager, U.S. Pat. No. 6,462,159 to Hamada, U.S. Pat. No. 6,752,905 to Chuang et al. and so forth. Examples of suitable thermoplastic binder fibers include, but are not limited to, monocomponent and multi-component fibers having at least one relatively low melting thermoplastic polymer such as polyethylene. In certain embodiments, polyethylene/polypropylene sheath/core staple fibers can be used. Binder fibers may have lengths described herein above in relation to the synthetic cellulosic fibers.


Binders in liquid form, such as latex emulsions, can comprise between about 0% and about 10% of the slurry. In certain embodiments the non-fibrous binder can comprise between about 0.1% and 10% of the slurry or even between about 0.2% and about 5% or even between about 0.5% and about 2% of the slurry. Binder fibers, when used, may be added proportionally to the other components to achieve the desired fiber ratios and structure while maintaining the total solids content of the slurry below the amounts stated above.


Strength Additives


One or more wet strength additives may, optionally, be added to the slurry in order to help improve the relative strength of the ultra-low density paper tissue sheet. Such strength additives suitable for use with paper making fibers and the manufacture of paper tissue are known in the art.


Temporary wet strength additives may be cationic, nonionic or anionic. Examples of such temporary wet strength additives include PAREZ™ 631 NC and PAREZ® 725 temporary wet strength resins that are cationic glyoxylated polyacrylamides available from Cytec Industries, located at West Paterson, N.J. These and similar resins are described in U.S. Pat. No. 3,556,932 to Coscia et al. and U.S. Pat. No. 3,556,933 to Williams et al. Additional examples of temporary wet strength additives include dialdehyde starches and other aldehyde containing polymers such as those described in U.S. Pat. No. 6,224,714 to Schroeder et al.; U.S. Pat. No. 6,274,667 to Shannon et al.; U.S. Pat. No. 6,287,418 to Schroeder et al.; and U.S. Pat. No. 6,365,667 to Shannon et al., and so forth.


Permanent wet strength agents comprising cationic oligomeric or polymeric resins may be used in the present invention. Polyamide-polyamine-epichlorohydrin type resins such as KYMENE 557H sold by Hercules, Inc. located at Wilmington, Del. are the most widely used permanent wet-strength agents and are suitable for use in the present invention. Such materials have been described in the following U.S. Pat. No. 3,700,623 to Keim; U.S. Pat. No. 3,772,076 to Keim; U.S. Pat. No. 3,855,158 to Petrovich et al.; U.S. Pat. No. 3,899,388 to Petrovich et al.; U.S. Pat. No. 4,129,528 to Petrovich et al.; U.S. Pat. No. 4,147,586 to Petrovich et al.; U.S. Pat. No. 4,222,921 to van Eenam and so forth. Other cationic resins include polyethylenimine resins and aminoplast resins obtained by reaction of formaldehyde with melamine or urea. Permanent and temporary wet strength resins may be used together in the manufacture of tissue sheets and tissue products of the present invention.


Dry strength resins may also optionally be applied to the tissue sheet of the present invention. Such materials may include, but are not limited to, modified starches and other polysaccharides such as cationic, amphoteric, and anionic starches and guar and locust bean gums, modified polyacrylamides, carboxymethylcellulose, sugars, polyvinyl alcohol, chitosan, and the like.


The strength additives can comprise between about 0.01 and about 5% of the slurry. In certain embodiments the strength additives can comprise between about 0.05% and about 2% of the slurry or even between about 0.1% and about 1% of the slurry.


Additional Additives.


Other additional components may be added to the slurry so long as they do significantly interfere with the formation of the highly-expanded stable foam, the hydrogen bonding as between the cellulosic fibers or other desired properties of the web. As examples, additional additives may include one or more pigments, opacifying agents, anti-microbial agents, pH modifiers, skin benefit agents, fragrances and so forth as desired to impart or improve one or more physical or aesthetic attributes. In certain embodiments the tissue sheet may include skin benefit agents such as, for example, antioxidents, astringents, conditioners, emollients, deodorants, external analgesics, film formers, humectants, hydrotropes, pH modifiers, surface modifiers, skin protectants, and so forth. When employed, miscellaneous additives desirably comprise less than about 2% of the slurry and still more desirably less than about 1% of the slurry and even less than about 0.5% of the slurry.


Formation of the Tissue Sheet


Formation of Highly-Expanded Foam


The foam precursor or slurry is acted upon to form a highly-expanded foam. More specifically, the slurry is acted upon so as to form a highly porous foam having an air content greater than about 50% by volume and, more desirably, greater than about 60% by volume. In certain aspects, the highly-expanded foam is formed having an air content of between about 60% and about 95% and in further aspects between about 65% and about 85% by volume. In certain embodiments, the highly-expanded foam may be acted upon to introduce air bubbles such that the ratio of expansion (volume of air to slurry in the expanded stable foam) is greater than 1:1 and in certain embodiments the ratio of slurry:air can be between about 1:1.1 and about 1:20 or between about 1:1.5 and about 1:15 or between about 1:2 and about 1:10 or even between about 1:3 and about 1:5.


The highly-expanded foam can be generated by one or more means known in the art. Examples of suitable methods include, without limitation, aggressive mechanical agitation, injection of compressed air, and so forth. Mixing the components through the use of a high-shear, high-speed mixer is particularly well suited for use in the formation of the desired highly-porous foams. Various high-shear mixers are known in the art and believed suitable for use with the present invention. High-shear mixers typically employ a tank holding the foam precursor and/or one or more pipes through which the foam precursor is directed. The high-shear mixers may use a series of screens and/or rotors to work the precursor and cause aggressive mixing of the components and air. In a particular embodiment, a tank is provided having therein one or more rotors or impellors and associated stators. The rotors or impellors are rotated at high speeds in order to cause flow and shear as a result of the speed of the slurry at the tip of the rotor being higher than that at the center of the rotor. Air may, for example, be introduced into the tank at various positions or simply drawn in by the action of the mixer. While the specific mixer design may influence the speeds necessary to achieve the desired mixing and shear, in certain embodiments suitable rotor speeds may be at least about 1000 rpm and, for example, be between about 1000 rpm and about 6000 rpm or between about 2000 rpm and about 4000 rpm. In certain embodiments, with respect to rotor based high-shear mixers, the mixer maybe run with the foam slurry until the disappearance of the vertex in the slurry.


In addition, it is noted the foaming process can be accomplished in a single foam generation step or in sequential foam generation steps. For example, in one embodiment, all of the components may be mixed together to form a foam slurry from which a highly-expanded foam is formed. Alternatively, one or more of the individual components may be added to the foaming fluid, an initial mixture formed (e.g. a dispersion or foam), after which the remaining components may be added to the initially foamed slurry and then acted upon to form the final highly-expanded foam. In this regard, the water and foaming surfactant may be initially mixed and acted upon to form an initial foam. The cellulosic fibers may then be added to the water/surfactant foam and then further acted upon to form the final highly-expanded foam. As a further alternative, the water and fibers may be aggressively mixed to form an initial dispersion after which the foaming surfactant and other components are added to form a second mixture which is then mixed and acted upon to form the highly-expanded foam.


Tissue Sheet Formation


The highly-expanded foam, once formed, can be acted upon so as to remove the foaming fluid, without substantial loss or degradation of the porous structure, so as to form an ultra-low density paper tissue web. Typically, this will comprise drying of the highly-expanded foam in a non-compressive manner. The highly-expanded foam can be dried by one or more means known in the art such as, for example, heating by radiation such as microwaves or infrared radiation, inductively heated, heated by conduction or convection, such as by gentle (non-compressive) through-air drying, or the like. As an example, and with respect to through-air drying, the highly-expanded foam can be fed onto a foraminous fabric or screen (i.e. a forming fabric) and hot, dry air directed though the foam. In this regard, desirable flow rates are sufficiently low so as not to cause significant compression and/or degradation of the air bubbles strewn throughout the material. Alternatively, a sheet of high-expanded foam can be placed into a convection oven and heated to the desired degree. It will be appreciated that temperatures used in the drying operation should not be so high as to excessively melt any binder fiber that may be present nor so high as to cause significant loss of air bubbles within the material. The foam is desirably dried to achieve a paper tissue web wherein less than about 10% of the foaming liquid and/or water remains. In certain embodiments, the dried paper tissue web will have a water content of between about 1% and about 8% or further between about 2% and 5%.


In one aspect, the highly-expanded foam may be directed onto and spread across a forming fabric or mold to form a sheet-like structure. The spread and height of the foam will be selected in relation and/or proportional to the desired dimensions of the dried cellulosic web.


Cellulosic Product


Once dried, the cellulosic tissue sheet of the present invention will have very low densities, such as below 0.5 g/cc. In this regard, the cellulosic tissue sheet can have a density below about 0.04 g/cc such as for example, having a density between about 0.04 g/cc and about 0.005 g/cc, between about 0.02 g/cc and about 0.005 g/cc or even between about 0.099 g/cc and about 0.005 g/cc. Relatedly, in certain aspects, the cellulosic tissue sheet can comprise a highly porous structure having network of inter-connected pores extending through the thickness of the sheet. In certain embodiments, a significant number and/or majority of pores having a substantially spherical shape.


Further, the cellulosic tissue sheet can comprise greater than 50% by wt. cellulosic fibers and in certain embodiments can comprise greater than 70%, 85%, or even 95% by wt. cellulosic fibers. In certain embodiments, the cellulosic fibers can comprise 100% of the fibrous component of the tissue sheet including, for example, comprising between about 55%-100% by wt. or between about 85%-100% by wt. of the fibrous component of the tissue sheet. Further, in certain embodiments, the cellulosic tissue sheet can include less than about 30%, less than 10% or less than 2% by wt. binder. In certain embodiments, the tissue sheet can include, for example, between 0-30% by wt. binder, between 0.1%-10% or between about 0.1%-2% by wt. binder.


Depending on the method of drying the foam, a portion of the foaming surfactant may have been removed with the water. However, regardless of the drying method, an amount of foaming surfactant will remain on the fibers and within the foamed tissue sheet. In this regard, the cellulosic tissue web can include between about 0.01% and about 5% by wt. foaming surfactant. In certain embodiments the tissue sheet can comprise between about 0.05% and about 3% or between about 0.5% and 3% or even between about 0.1% and about 1% by wt. foaming surfactant. Similarly, the foam stabilizer, when used, may be present in the dried paper tissue web in an amount between 0 and about 2% by wt., or between about 0.01% and about 2% by wt. or even between about 0.05% and about 1% by wt. Further, the strength enhancing agents, when used, may be present in the cellulosic tissue sheet in an amount between about 0.01% and about 5% by wt. and in other embodiments between about 0.5% and about 2% by wt.


In addition, despite the ultra-low density of the sheet and high cellulosic fiber content, it can have low lint properties. More specifically, the tissue sheet can have Gelbo Lint Value Gelbo Lint Value less than 5 and more desirably less than 4 and still more desirably less than 3. In certain embodiments, for particles having a size of at least 0.10 mm, the tissue sheet can have a modified Gelbo Lint Value of less than 5 and more desirably less than 4 and still more desirably less than 3. Further, in certain embodiments, the cellulosic tissue sheet can have a wet tensile strength of at least about 10 g-f such as, for example, between about 15 and about 500 g-f or between about 20 and about 300 g-f.


The thickness and basis weight of the sheet can be selected as desired to fulfill the needs of the particular personal care article and/or component thereof. In this regard, the cellulosic tissue sheet can have a thickness selected to provide the desired degree of absorbency and/or bulk, and in certain aspects can have a thickness between about 0.5 and about 45 mm or, in alternate embodiments, between about 1 mm and 30 mm. The cellulosic tissue sheet may be converted into a wiping article, personal care article or a component of such articles through one or more known ways in the art. The size of the cellulosic tissue sheet may be shaped and/or sized as needed to provide sufficient bulk, surface area and/or perform the intended function either alone or as a component in a multi-component article.


Wiping Articles


With respect to uses as a wiping article such as, for example, as a facial tissue, cosmetic wipe, toilet tissue, table napkin, or other wiping article, the cellulosic tissue sheet can have a thickness of between about 0.5 mm and about 5 mm or, in other embodiments between about 1 mm about 3 mm. In certain embodiments, for wiping or cleaning applications and articles, the cellulosic tissue can have a basis weight of at least about 10 g/M2 (or gsm) such as for example, having a basis weight of between about 10 gsm and about 100 gsm or between about 15 gsm and about 90 gsm or even between about 20 gsm and about 80 gsm.


With respect to a wiping and/or cleaning product, the size of the article 10 may be shaped and/or sized to provide sufficient surface area to enable a user to clean and/or treat the intended body part(s). By way of example, for many personal care applications it will be adequate for the article 10 to have a maximum diameter of between about 5-45 cm or, in other embodiments, between about 7 and about 35 cm or between about 10 cm and about 30 cm. For certain personal care products, including use as a facial cleansing and/or cosmetic product, the article 10 desirably has a length of between 5-30 cm and a width between about 5-30 cm, including for example, having dimensions between 25 cm (L)×25 cm (W) and (5 cm (L)×5 cm (W). The shape of the article 10 may vary as desired and may comprise rectilinear, curvilinear and irregular shapes. By way of example, the article may be circular, elliptical, oval, square, rectangular, multi-lobal and so forth.


Wiping and/or cleaning articles of the present invention can, in certain aspects, comprise multi-ply products wherein at least one of the layers comprises the ultra-low density cellulosic tissue web described herein. The individual layers may, in one aspect, be separately formed and then attached to one another by one or more means known in the art such as, for example, by adhesives, “crimp” or compressive bonding (e.g. application of pressure), thermal bonding (e.g. where a layer includes one or more thermoplastic binder fibers), and so forth. In one aspect, the multi-ply webs may be pattern embossed. Such embossing and/or plying techniques are known in the art and examples include, but are not limited to, those described in U.S. Pat. No. 3,867,225 Nystrand; U.S. Pat. No. 4,320,162 to Schulz; U.S. Pat. No. 305,181 to Veith and so forth. In addition and/or alternatively, the ultra-low density paper tissue web may be formed directly on or with a second layer to form an integrated and/or coherent multi-layer laminate.


In certain aspects, the tissue product may comprise a multi-layer or multi-ply product comprising a first tissue web comprising an ultra-low density tissue web as described herein and a second paper tissue web having one or more different properties from that of the ultra-low density paper tissue web. In one aspect, the second paper tissue web can have a density of between 0.5 g/cc and 0.04 g/cc or, in further embodiments, a density between about 0.3 g/cc and about 0.05 g/cc. Further, the second tissue sheet can have a basis weight between about 10 to about 100 gsm or between about 20 and about 90 gsm. For certain facial tissue products, each of the layers can have a basis weight between about 10 to about 20 gsm. However, for heavier duty paper products such as a paper towel, in certain embodiments, each of the layers may have a basis weight between about 15 gsm and about 40 gsm. The thickness of the sheets may, in certain embodiments, be between about 0.5 mm and about 5 mm or, in other embodiments, between about 1 mm about 3 mm. The second ply can, in certain embodiments, comprise at least about 95% cellulosic fibers, at least about 98% cellulosic fibers or at least about 99% cellulosic fibers. Further, the fibers making up the second ply can, in certain embodiments, comprise entirely (100%) cellulosic fibers. The second ply can, in one aspect, comprise a wet-formed tissue sheet. Wet formed tissue sheets formed by a through-air drying process are well suited for use in conjunction with the foamed tissue sheet of the present invention; such tissue webs are generally characterized by relatively higher bulk and absorbency than convention wet-pressed tissue and in certain embodiments can be formed with a surface texture to improve cleaning efficacy and/or hand. Tissue sheets of this type are described in and formed by methods described in U.S. Pat. No. 4,191,609 to Trokhan; U.S. Pat. No. 5,443,691 to Van Phan et al.; U.S. Pat. No. 5,672,248 to Wendt et al.; U.S. Pat. No. 6,787,000 Burazin et al.; US2015/0176221 Malden et al., and WO2015/080726 to Burazin et al.; the contents of which are incorporated herein by reference to the extent consistent herewith. Further, in certain embodiments the second web may comprise a wet-formed tissue sheet dried by a wet-press process and which is characterized by relatively higher density and more compact, planar fiber orientation. Such tissue webs are often dried on a Yankee drier and creped on one or both sides to further increase bulk and improve sheet strength. Tissue sheets of this type are described in and formed by methods described in U.S. Pat. No. 4,894,118 Edwards et al.; U.S. Pat. No. 4,942,077 Kessner et al.; U.S. Pat. No. 6,454,904 Hermans et al.; WO2015/066036 to Bradley et al., the contents of which are incorporated herein by reference to the extent consistent herewith.


In certain embodiments, the multi-ply tissue product of the present invention can comprise an ultra-low density tissue web as described herein attached to a nonwoven web. Nonwoven webs can be formed from many processes, such as, for example, meltblowing processes, spunbonding processes, air-laying processes, coforming processes, bonded carded web processes, hydroentangling processes and so forth. By way of non-limiting example, various nonwoven webs and processes for making the same are described in U.S. Pat. No. 3,849,241 to Butin et al., U.S. Pat. No. 4,340,563 to Appel et al., U.S. Pat. No. 4,443,513 to Meitner et al., U.S. Pat. No. 4,548,856 to Ali Kahn et al., U.S. Pat. No. 4,853,281 to Abba et al., U.S. Pat. No. 5,382,400 to Pike et al., U.S. Pat. No. 5,575,874 to Griesbach et al., U.S. Pat. No. 6,224,977 to Kobylivker et al., U.S. Pat. No. 6,811,638 to Close et al., U.S. Pat. No. 6,946,413 to Lange et al., US2004/0192136 to Gusky et al., US2006/0008621 to Gusky et al., U.S. Pat. No. 4,100,324 to Anderson et al., U.S. Pat. No. 5,350,624 to Georger et al., US2011/151596 to Jackson et al., U.S. Pat. No. 3,485,706 to Evans, U.S. Pat. No. 3,620,903 to Bunting et al., U.S. Pat. No. 5,009,747 Viazmensky et al., U.S. Pat. No. 5,284,703 to Everhart et al., U.S. Pat. No. 6,200,669 to Marmon et al., and so forth. In certain aspects the nonwoven webs can have a basis weight of from about 15 gsm to about 240 gsm or, in alternate embodiments, between about 20-190 gsm or between about 25-90 gsm. In this regard, the fibrous material includes greater than about 25% by weight synthetic fibers and in certain embodiments between about 40%-100% synthetic fibers and in still further embodiments between about 55%-100% synthetic fibers. The synthetic fibers may comprise polymers such as, for example, polyolefin, polyester, polyamide, polylactic acid, or other fiber forming polymers.


In a further aspect, a multi-ply product of the present invention can comprise an ultra-low density cellulosic tissue product as described herein plied to a nonwoven web of cellulosic synthetic fibers such as, for example, viscose. In one aspect, a multi-ply product can comprise an ultra-low density tissue product described herein attached to a biodegradable and/or flushable nonwoven web. Examples of biodegradable and/or flushable nonwoven fabrics include, but are not limited to, those described in U.S. Pat. No. 5,948,710 to Pomplun et al., U.S. Pat. No. 5,667,635 Win et al., U.S. Pat. No. 6,043,317 to Mumick et al., WO2007/110497 to Noelle, US2011/0290437 to Vogel et al., US2015/118466 Zwick et al., and so forth.


In certain embodiments, the ultra-low density tissue web described herein may comprise an outer layer or ply in the multi-ply laminate. In alternate embodiments, the multi-layer tissue product may comprise 3 or more layers. In certain such embodiments and in relation to a multi-ply web having 3 or more plies, the ultra-low density tissue web described herein may comprise an inner or central ply and wherein first and second outer plies can comprise wet-laid paper tissue webs or nonwoven webs described herein above. Further, in such embodiments the first and second outer plies may be the same or different materials.


The wiping products can be provided in a stack and incorporated or oriented in a container as desired. Further, the stack of sheets can be folded as desired in order to improve efficiency of use and/or dispensing. The stack(s) of the tissue products are desirably arranged to facilitate removal or dispensing, and in certain embodiments, can be arranged to facilitate metered dispensing. The sheets may be inter-folded in various know overlapping configurations such as, for example, V-folds, Z-folds, W-folds, quarter-folds and so forth. Equipment and processes for forming dispensable stacks of wipes are known in the art; examples of which include, but are not limited to, those described in U.S. Pat. No. 3,401,927 to Frick et al.; U.S. Pat. No. 4,502,675 to Clark et al.; U.S. Pat. No. 5,310,398 to Onekama, U.S. Pat. No. 6,612,462 to Sosalla et al., and so forth. With respect to product formats utilizing a continuous length of sheet material, such as in certain rolled formats, the individually separable wet wipes desirably have perforated or over-bonded lines of weakness which allow separation into smaller individual sheets of a desired shape and size. The particular stack height and sheet count can vary with the intended format and use. However, in certain embodiments, the stack may include between 3 and 250 individual tissue products, in further embodiments may include between about 10 and 150 tissue products and in still further embodiments may include between about 10 and 90 tissue products.


The stack of tissue products may be housed within a container adapted for the maintenance and/or dispensing of wiping products. Numerous such containers, e.g. packages and/or dispensers, are known in the art and suitable for use herewith. In one aspect, the container includes a plurality of walls defining an interior space. In one aspect, the container may comprise a flexible pack formed by thin polymeric film and optionally further having a resealable or reclosable dispensing opening for accessing the tissue products contained therein. Examples of flexible packaging dispensers include, but are not limited to, those described in U.S. Pat. No. 4,863,064 to Dailey, U.S. Pat. No. 5,524,759 Herzberg et al., U.S. Pat. No. 6,012,572 Heathcock et al., U.S. Pat. No. 7,527,152 to House et al., WO96/37138 Bauer et al., US2010/155284 Foley et al. and so forth. In addition, substantially rigid dispensers suitable for dispensing the paper tissue products of the present invention include, but are not limited to, those described in U.S. Pat. No. 3,369,700 Nelson et al., U.S. Pat. No. 3,369,699 Enloe et al., U.S. Pat. No. 5,785,179 Buczwinski et al., U.S. Pat. No. 7,028,840 Huang et al., U.S. Pat. No. 7,543,423 Long et al., US2005/211718 Decker et al., US2007/0235466 Fulscher et al., and so forth. In a particular embodiment, such as seen in reference to FIG. 1, a stack 22 of individual tissue products 20 may be positioned within a container or dispenser 24. The tissue stack 22 is located within the walls 24 of the dispenser 23 and may comprise the substantial majority of the interior space of the dispenser 23. The dispenser 23 can have at least one side panel, such as a top side panel 26, having a dispensing opening 28 through which the individual tissue sheets 20 can be removed. Commonly, the dispensing opening 28 will have a tab or cover (not shown) that is positioned over the dispensing opening but which is designed to be removed by the ultimate user at the time of use. To facilitate one at a time or metered dispensing, the dispensing opening 28 can have a flexible membrane or film 27 partially occluding the dispensing opening and designed to provide a frictional force on the tissue sheet 20 being removed and thereby facilitate proper separation of the individual tissue sheet 20 from the stack 22.


Personal Care Absorbent Articles


Absorbent personal care articles generally include a liquid permeable topsheet, which faces the wearer, and a liquid-impermeable backsheet or outer cover. Disposed between the topsheet and outer cover is an absorbent core. In this regard, the topsheet and outer cover are often joined and/or sealed to encase the absorbent core. Although certain aspects of the present invention are described in the context of a particular personal care absorbent article, it will be readily appreciated that similar uses in other types of personal care absorbent articles and/or further combinations or alterations of the specific configurations discussed below may be made by one skilled in the art without departing from the spirit and scope of the present invention.


In a particular embodiment, and in reference to FIG. 2, a diaper 50 can comprise a liquid-impervious outer cover 54, a liquid permeable topsheet 52 positioned in facing relation to the outer cover 54, and an absorbent core 56 between the outer cover 54 and topsheet 52. The diaper 50 may be of various shapes such as, for example, an overall rectangular shape, T-shape, hourglass shape and so forth. The topsheet 52 is generally coextensive with the outer cover 54 but may optionally cover an area that is larger or smaller than the area of the outer cover 54, as desired. While not shown, it is to be understood that portions of the diaper, such as a marginal section of the outer cover, may extend past and around the terminal edges of the product and form a portion of the body-facing layer. The diaper 50 also has end margins 62 adapted to fit about the waist of the wearer and a central region 64 designed to extend about the groin region as well as provide leg openings in combination with end margins 62. Fastening members 61 are commonly located adjacent the end margins 62 for securing the diaper about the wearer.


The topsheet or body-side liner 52, as representatively illustrated in FIG. 2, desirably presents a body facing surface which is compliant, soft to the touch, and non-irritating to the wearer's skin. The topsheet 52 is desirably employed to help isolate the wearer's skin from liquids held in the absorbent core 56. Topsheets are well known in the art and may be manufactured from a wide variety of materials, such as porous foams, reticulated foams, apertured plastic films, natural fibers (wool, cotton fibers, etc.), synthetic fibers (polyester, polypropylene, polyethylene, etc.), combinations of natural and synthetic fibers, and so forth. Topsheets can comprise a single layer or a multiple layers including a combination of one or more different materials. Nonwoven fabrics, and laminates thereof, are commonly utilized to form topsheets. Suitable topsheet materials include, but not limited to, those described in U.S. Pat. No. 5,382,400 to Pike et al.; U.S. Pat. No. 5,415,640 to Kirby et al.; U.S. Pat. No. 5,527,300 to Sauer; U.S. Pat. No. 5,994,615 to Dodge et al.; U.S. Pat. No. 6,383,960 to Everett et al.; U.S. Pat. No. 6,410,823 to Daley et al.; US2014/0121623 to Biggs et al. and so forth.


The backsheet or outer cover 54 comprises a liquid-impervious material. Desirably, the outer cover comprises a material that prevents the passage of water but allows air and water-vapor to pass there through. The outer cover can comprise a single layer of material or multiple layers including one or more layers of different materials. In a particular embodiment, the outer cover can comprise a film fixedly attached or bonded to one or more nonwoven webs. The particular structure and composition of the outer cover may be selected from various combinations of films and/or fabrics. In this regard, the outer most layers are generally selected for providing the desired strength, abrasion resistance, tactile properties and/or aesthetics. As an example, nonwoven fabrics are commonly employed as the outermost layer of the outer cover. Suitable outer covers include, but are not limited to, those described in U.S. Pat. No. 4,041,203 to Brock et al.; U.S. Pat. No. 6,075,179 et al. to McCormack et al.; U.S. Pat. No. 6,111,163 to McCormack s et al.; US2015/099086 to Cho et al. and so forth.


Between the liquid-impervious outer cover 54 and the liquid pervious topsheet 52 is positioned an absorbent core 56. The absorbent core may itself comprise a multiple layers having similar or different absorbent properties. In this regard, the absorbent core often includes one or more absorbent materials including, but not limited to, superabsorbent particles, wood pulp fibers, synthetic wood pulp fibers, synthetic fibers and combinations thereof. The absorbent core may have any of a number of shapes and the size of the absorbent core and selection of materials therein will vary with the desired loading capacity, the intended use of the absorbent article and other factors known to those skilled in the art. Examples of various absorbent core structures and/or additional absorbent materials that may be used in conjunction with the present invention include, but are not limited to, those described in U.S. Pat. No. 4,699,823 to Kellenberger et al.; U.S. Pat. No. 5,458,592 to Abuto et al; U.S. Pat. No. 5,601,542 to Melius et al.; U.S. Pat. No. 6,129,720 to Blenke et al.; U.S. Pat. No. 6,383,960 to Everett et al.; U.S. Pat. No. 7,938,813 to Elliker et al.; US2002/0183703 Dodge et al. and so forth. In one aspect, the absorbent core may include one or more layers, wherein at least one layer comprises the ultra-low density cellulosic tissue sheet described herein. In certain embodiments, the absorbent core may include a stack of ultra-low density cellulosic tissue sheets.


In addition, it is also common for the personal care absorbent article to employ a liquid distribution layer or “wicking” layer 58 above the absorbent core 56 in order to increase the span and/or regulate the speed with which the liquid coming into the absorbent article reaches the absorbent core. However, in other embodiments, the liquid transfer layer may alternatively and/or additionally be placed beneath the absorbent core (not shown). Such materials can comprise one or more nonwoven webs including for example, but not limited to multi-functional air-laid materials, apertured film/nonwoven laminates, high-loft nonwoven fabrics and so forth. Examples of various liquid distribution layers include, but are not limited to, those described in U.S. Pat. No. 5,364,382 to Latimer et al.; U.S. Pat. No. 6,437,214 to Bolwerk et al.; U.S. Pat. No. 6,534,149 Mace et al.; U.S. Pat. No. 6,617,490 Lindsay et al and so forth. In certain embodiments, the absorbent personal care article may include a liquid distribution layer comprising an ultra-low density cellulosic material described herein.


The personal care articles can, optionally, contain one or more additional elements or components. In this regard, numerous additional features and various constructions are known in the art. As but a few examples and in reference to FIG. 2, the diaper can further include elastic leg cuffs 65, an elastic waistband 60, fluid control flaps 66, and so forth. One skilled in the art will appreciate the application and use of the ultra-low density webs of the present invention in like manners for other absorbent personal care articles including, for example, adult incontinence garments, incontinence pads/liners, sanitary napkins, party-liners, sweat pads, bandages, and so forth. In addition, other absorbent articles that may include one or more layers of the ultra-low density webs of the present invention including, but are not limited to, baby bibs and changing pads, bed pads, food tray liners, and so forth.


The cellulosic tissue webs and products can, optionally, include one or more additional elements or components as are known in the art. Thus, while the invention has been described in detail with respect to specific embodiments and/or examples thereof, it will be apparent to those skilled in the art that various alterations, modifications and other changes may be made to the invention without departing from the spirit and scope of the same. It is therefore intended that the claims cover or encompass all such modifications, alterations and/or changes.


Definitions and Test Methods

In reference to the Figures and throughout the specification and claims, discussion of the articles and/or individual components thereof is with the following understanding:


The terms “comprising” or “including” or “having” are inclusive or open-ended and do not exclude additional unrecited elements, compositional components, or method steps. Accordingly, the terms “comprising” or “including” or “having” also encompass the more restrictive terms “consisting essentially of” and “consisting of”.


As used herein, the term “basis weight” generally refers to the bone dry weight per unit area of a tissue and is generally expressed as grams per square meter (gsm). Basis weight is measured using TAPPI test method T-220 sp-10.


As used herein, the term “nonwoven web” means a web having a structure of individual fibers or threads which are interlaid, but not in an identifiable manner as in a knitted web.


The term “personal care absorbent article” refers herein to an article intended and/or adapted to be placed against or in proximity to the body (i.e., contiguous with the body) of the wearer to absorb and contain various liquid, solid, and semi-solid exudates discharged from the body. Examples include, but are not limited to, diapers, diaper pants, training pants, youth pants, swim pants, feminine hygiene products, including, but not limited to, menstrual pads or pants, incontinence products, medical garments, surgical pads and bandages, and so forth.


The term “ply” refers to a discrete layer within a multi-layered product wherein individual plies may be arranged in juxtaposition to each other.


The term “plied” or “bonded” or “coupled” refers herein to the joining, adhering, connecting, attaching, or the like, of two elements. Two elements will be considered plied, bonded or coupled together when they are joined, adhered, connected, attached, or the like, directly to one another or indirectly to one another, such as when each is directly bonded to intermediate elements. The plying, bonding or coupling of one element to another can occur via continuous or intermittent bonds.


As used herein, unless expressly indicated otherwise, when used in relation to material compositions the terms “percent”, “percent”, “weight percent” or “percent by weight” each refer to the quantity by weight of a component as a percentage of the total.


As used herein, the term “stack” is used broadly to include any collection of sheets wherein there is a plurality of individual sheets having surface-to-surface interfaces; this not only includes a vertically stacked collection of individual sheets, but also includes a horizontally stacked collection of individual sheets as well as a rolled or folded collection of continuous sheet material separated by lines of weakness (e.g. perforations).


As used herein “caliper” or “thickness” of a sheet is determined by using a micrometer having an acrylic platen with a pressure foot area of 45.6 cm2 (3 inch diameter), providing a load of 0.345 kPa (0.5 psi), and the reading is taken after a dwell time of 3 seconds. A sample is cut having a size of 90×102 mm (3.5×4 inches) is used for the measurement.


As used herein “Gelbo Lint Value” is determined in accordance with INDA Standard Procedure 160.1.RO (12) using the counting method C. This test determines the relative number of particles released from a fabric when it is subjected to a flexing and twisting movement.


As used herein “tensile” strength, “Dry Tensile Strength” or “Wet Tensile Strength”, is the peak load value, i.e. the maximum force produced by a specimen when it is pulled to rupture. Samples for tensile strength testing are prepared by cutting a 76 mm wide strip of the sheet to be tested and then conditioning the specimen by hanging in an oven at 105 C for six minutes. The instrument used for measuring tensile strengths is an Instron Tensile Tester and the data acquisition software is MTS TestWorks™ for Windows Ver. 4 (MTS Systems Corp., Research Triangle Park, NC). The load cell is selected from either a 50 Newton or 102 Newton maximum, depending on the strength of the sample being tested, such that the majority of peak load values fall between 10 and 90 percent of the load cell's full scale value. The gauge length between jaws is 100 mm. The jaws are operated using pneumatic-action and are rubber coated. The grip face width is 76, and the approximate height of a jaw is 13 mm. The crosshead speed is 254 mm/minute, and the break sensitivity is set at 65 percent, slack compensation is set at 25 g. The sample is placed in the jaws of the instrument, centered both vertically and horizontally. The test is then started and ends when the specimen breaks. The peak load is recorded as either the “MD tensile strength” or the “CD tensile strength” of the specimen depending on the sample being tested. Six (6) representative specimens are tested for each product, and the arithmetic average of all individual specimen tests is either the MD or CD tensile strength for the product. For purposes of the present invention, the tensile refers to the higher value of the CD or MD as applicable. Wet tensile strength measurements are measured in the same manner, with the exception that the center portion of the previously conditioned sample strip has been saturated with distilled water immediately prior to loading the specimen into the tensile test equipment. Sample wetting is performed by first laying a single test strip onto a piece of blotter paper (Fiber Mark, Reliance Basis 120). A pad is then used to wet the sample strip prior to testing. The pad is a green, Scotch-Brite brand (3M) general purpose commercial scrubbing pad. To prepare the pad for testing, a full-size pad is cut approximately 2.5 inches long by 4 inches wide. A piece of masking tape is wrapped around one of the 4-inch long edges. The taped side then becomes the “top” edge of the wetting pad. To wet a tensile strip, the tester holds the top edge of the pad and dips the bottom edge in approximately 0.25 inches of distilled water located in a wetting pan. After the end of the pad has been saturated with water, the pad is then taken from the wetting pan and the excess water is removed from the pad by lightly tapping the wet edge three times across a wire mesh screen. The wet edge of the pad is then gently placed across the sample, parallel to the width of the sample, in the approximate center of the sample strip. The pad is held in place for approximately one second and then removed and placed back into the wetting pan. The wet sample is then immediately inserted into the tensile grips so the wetted area is approximately centered between the upper and lower grips. The test strip should be centered both horizontally and vertically between the grips. (It should be noted that if any of the wetted portion comes into contact with the grip faces, the specimen must be discarded and the jaws dried off before resuming testing.) The tensile test is then performed and the peak load recorded to obtain the wet tensile strength.


EXAMPLES

The below examples were made according to the following process. A total of 2000 grams of a slurry was added into a disintegrator's cup for fiberizing wood pulp fiber. The slurry was formed to having a fiber consistency of about 2%. 40 grams of dry commercial densified wood pulp sheet and, where applicable additional fibers, were weighed according to fiber mixture weight ratio and placed into the British standard disintegrator's cup. 1960 grams of distilled water was added into the cup and the fiber mixture was soaked for 5 minutes. The cup was then mounted onto the disintegrator and ran for 15,000 revolutions to sufficiently fiberize the wood pulp fiber. After this, 500 grams of the slurry was weighed in a separate container having a dimension of 150 mm in diameter and 170 mm in height and 6.5 grams of 10% sodium dodecyl sulfate solution was added into the container. The surfactant concentration in the slurry was about 0.13 weight percent. The slurry was mixed by a high speed rotary mixer at a speed of 4000 rpm for several minutes until the vertex inside the container disappeared.


The foam formed fiber slurry was then shaped into a sheet by two different ways. Method 1 was to pour entire foamed slurry into a lab hand sheet former with an area dimension of 10 inches by 10 inches. Method 2 was to control thickness of the wet foam sheet by push it through a gap with the gap height controlled through the use of different diameter metal rods.


The foam sheets were dried in an oven at 90° C. for about 2 to 3 hours. Optionally, the dried base sheets were subsequently heat cured at a temperature suitable to activate binder fiber to achieve its thermo-bonding.


Example 1

Foam formed base sheet comprising only wood pulp fiber; the wood pulp fiber consisted of a mixture of northern softwood kraft fiber (LL-19) and Eucalyptus fiber.


Example 2

Foam formed base sheet comprising both wood pulp fiber and a binder fiber. The wood pulp fiber consisted of a mixture of northern softwood kraft fiber (LL-19) and Eucalyptus fiber. The binder fiber comprised Trevira T255-6 polyethylene/PET sheath/core staple fiber with a 6 mm fiber length and 2.2 dtex. After drying, the web was further heated at 130 C for one hour cured in order to activate the binder fiber.


The low density webs of the examples were tested and the properties are reported in the table below.









TABLE 1







A Summary of Different Base Sheets with Compositions & Certain Basic Properties










Foam Forming Slurry Composition












Binder

Properties

















Pulp

Fiber
Surfactant

Basis



Sample
Base Sheet
Euc
LL-19
T255-6
SDS
Water
Weight
Density


No.
Description
(g)
(g)
(g)
(g)
(g)
(g/m2)
(g/cm3)


















1
Foam
10.5
4.5

0.65
485
135
0.016



Formed


2
Foam
10.5
4.5
1.5
0.65
485
139
0.0157



Formed
















TABLE 2







A Summary of Tensile Testing and Lint Content Testing Results











Average Number of Linting Particles



Tensile
Shaking Out from the Substrates











Testing Results

Lint














Dry
Wet

>10.0

Content


Code ID
(g · force)
(g · force)
>5.0 μm
μm
>25.0 μm
(Sum)
















1
116
22
1.6
0.8
0.4
2.8


2
920
255
0.8
0.7
0.1
1.6








Claims
  • 1. A tissue paper product comprising: a first ply having a highly porous, open-celled structure comprising cellulosic fibers, a water insoluble binder and a foaming surfactant, wherein the water insoluble binder comprises thermoplastic binder fibers, and wherein the cellulosic fiber comprises greater than 50% by weight of the first ply;said cellulosic fibers of said first ply are bonded to one another by hydrogen bonding; andwherein said first ply has a density less than about 0.04 g/cc, Gelbo Lint Value less than 5 and a wet tensile strength of at least 10 g-f.
  • 2. The tissue paper product of claim 1 wherein said first ply has a substantially planar, sheet-like structure having a thickness of between about 0.5 and about 5 mm.
  • 3. The tissue paper product of claim 1 wherein said thermoplastic binder fibers comprise less than about 10% by weight of said first ply.
  • 4. The tissue paper product of claim 1 further comprising a wet strength resin adhered to said cellulosic fibers and selected from the group consisting of cationic oligomeric or polymeric resins.
  • 5. The tissue paper product of claim 2 wherein the density of said first ply is between about 0.02 g/cc and about 0.005 g/cc.
  • 6. The tissue paper product of claim 1 wherein said foaming surfactant is selected from cationic and anionic surfactants and is present in said first ply in an amount between about 0.1 and about 5%.
  • 7. The tissue paper product of claim 1 further comprising a second ply comprising a wet-laid tissue including at least 95% wood pulp fibers by weight of the second ply and having a density between about 0.5 and 0.04 g/cc, and further wherein said first and second plies are attached to one another.
  • 8. The tissue paper product of claim 7 wherein the first and second plies are pattern embossed.
  • 9. The tissue paper product of claim 7 further comprising a third ply comprising a wet-laid tissue including at least 95% wood pulp fibers by weight of the third ply and having a density between about 0.5 and 0.04 g/cc, and wherein said first ply is positioned between said second and third plies and said first, second and third plies are attached to one another.
  • 10. A packaged wiping product comprising: a container defining an interior space;a stack of between 3 and 150 individual wiping sheets, said stack located within said interior space;said wiping sheets comprising the tissue paper product of claim 1.
  • 11. The packaged wiping product of claim 10 wherein said container has a reclosable dispensing opening.
  • 12. The packaged wiping product of claim 10 wherein said container has a dispensing opening and a flexible film partially occluding said dispensing opening.
  • 13. The packaged wiping product of claim 11 wherein the density of said first ply is between about 0.02 g/cc and about 0.005 g/cc.
  • 14. The packaged wiping product of claim 13 further comprising a second ply comprising a wet-laid tissue including at least 95% wood pulp fibers by weight of the second play and having a density between about 0.5 and 0.04 g/cc, and further wherein said first and second plies are attached to one another.
  • 15. The packaged wiping product of claim 14 wherein said stack comprises either (i) a roll of individual wiping sheets separated by lines of perforation or (ii) superposed, inter-folded wiping sheets.
  • 16. A personal care absorbent article comprising: a liquid pervious body-side liner;a liquid impervious outer cover;an absorbent core, said absorbent core is located between and said body-side liner and said outer cover; andwherein the absorbent core includes the tissue paper product of claim 1.
  • 17. The absorbent personal care article of claim 16 wherein the first ply of said tissue paper product has a sheet-like structure having a thickness of between about 5 mm and about 40 mm and a density of between about 0.02 g/cc and about 0.005 g/cc.
  • 18. The absorbent personal care article of claim 17 wherein the absorbent core further includes superabsorbent particles.
  • 19. A personal care absorbent article comprising: a liquid pervious body-side liner;a liquid impervious outer cover;an absorbent core, said absorbent core is located between and said body-side liner and said outer cover; anda liquid transfer layer superposed with said absorbent core and located between and said body-side liner and said outer cover; andwherein the liquid transfer layer includes the tissue paper product of claim 1.
  • 20. The absorbent personal care article of claim 19 wherein the first play of said tissue paper has a sheet-like structure having a thickness of between about 0.5 and about 5 mm and a density between about 0.02 g/cc and about 0.005 g/cc.
  • 21. The tissue paper product of claim 1, wherein the Gelbo Lint Value is less than 2.8.
  • 22. The tissue paper product of claim 1, wherein the tissue paper product is free from a polymeric foamable binder material.
Parent Case Info

This application claims the benefit of priority from U.S. Provisional Application No. 62/250,242 filed on Nov. 3, 2015, the contents of which are incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2016/059931 11/1/2016 WO
Publishing Document Publishing Date Country Kind
WO2017/079169 5/11/2017 WO A
US Referenced Citations (786)
Number Name Date Kind
2105711 Weathered Jan 1938 A
2791523 Schoen May 1957 A
3007840 Wilcox Nov 1961 A
3369699 Enloe Feb 1968 A
3369700 Nelson Feb 1968 A
3401927 Frick Sep 1968 A
3485706 Evans Dec 1969 A
3506538 Friedberg et al. Apr 1970 A
3542640 Friedberg et al. Nov 1970 A
3556932 Coscia Jan 1971 A
3556933 Coscia Jan 1971 A
3585104 Kleinert Jun 1971 A
3615975 Gillern et al. Oct 1971 A
3620903 Wallar, Jr. Nov 1971 A
3700623 Keim Oct 1972 A
3716449 Gatward et al. Feb 1973 A
3772076 Keim Nov 1973 A
3798122 Appel Mar 1974 A
3837999 Chung Sep 1974 A
3839142 Clarke et al. Oct 1974 A
3849241 Butin Nov 1974 A
3855158 Petrovich Dec 1974 A
3867225 Nystrand Feb 1975 A
3871952 Robertson Mar 1975 A
3899388 Petrovich Aug 1975 A
3929560 Holik et al. Dec 1975 A
3938782 Robertson Feb 1976 A
3966540 Selander et al. Jun 1976 A
4007083 Ring et al. Feb 1977 A
4041203 Brock Aug 1977 A
4049491 Brandon et al. Sep 1977 A
4062721 Guyer et al. Dec 1977 A
4100324 Anderson Jul 1978 A
4123787 Leclerc du Sablon et al. Oct 1978 A
4129528 Petrovich Dec 1978 A
4147586 Petrovich Apr 1979 A
4191609 Trokhan Mar 1980 A
4200488 Brandon et al. Apr 1980 A
4222921 Van Eenam Sep 1980 A
4285767 Page Aug 1981 A
4288475 Meeker Sep 1981 A
4299655 Skaugen Nov 1981 A
4320162 Schulz Mar 1982 A
4340563 Appel Jul 1982 A
4394930 Korpman Jul 1983 A
4415388 Korpman Nov 1983 A
4443232 Kaiser Apr 1984 A
4443297 Cheshire et al. Apr 1984 A
4443299 Cheshire et al. Apr 1984 A
4443513 Meitner Apr 1984 A
4464224 Matolcsy Aug 1984 A
4478615 Kaiser Oct 1984 A
4498956 Cheshire et al. Feb 1985 A
4502675 Clark Mar 1985 A
4543156 Cheshire et al. Sep 1985 A
4548856 Ali Khan Oct 1985 A
4559243 Passler et al. Dec 1985 A
4594130 Chang Jun 1986 A
4613627 Sherman et al. Sep 1986 A
4655950 Michalek Apr 1987 A
4686006 Cheshire et al. Aug 1987 A
4699823 Kellenberger Oct 1987 A
4734321 Radvan et al. Mar 1988 A
4764253 Cheshire et al. Aug 1988 A
4773408 Cilento et al. Sep 1988 A
4773409 Cilento et al. Sep 1988 A
4778477 Lauchenauer Oct 1988 A
4785030 Noda Nov 1988 A
4793898 Laamanen Dec 1988 A
4853281 Win Aug 1989 A
4863064 Dailey Sep 1989 A
4883478 Lerailler et al. Nov 1989 A
D305181 Veith Dec 1989 S
4894118 Edwards Jan 1990 A
4939030 Tsuji et al. Jul 1990 A
4940513 Spendel Jul 1990 A
4942077 Wendt Jul 1990 A
4944843 Wallace et al. Jul 1990 A
4948007 Berg et al. Aug 1990 A
4952448 Bullock et al. Aug 1990 A
4969975 Biggs et al. Nov 1990 A
4973382 Kinn et al. Nov 1990 A
4985467 Kelly et al. Jan 1991 A
5006373 Woodmansee et al. Apr 1991 A
5008306 Goguelin Apr 1991 A
5009747 Viazmensky Apr 1991 A
5013405 Izard May 1991 A
5064653 Sessions et al. Nov 1991 A
5065752 Sessions et al. Nov 1991 A
5073416 Avakian et al. Dec 1991 A
5098778 Minnick Mar 1992 A
5102501 Eber et al. Apr 1992 A
5134959 Woodmansee et al. Aug 1992 A
5137551 Ahrens et al. Aug 1992 A
5147345 Young et al. Sep 1992 A
5153058 Hall et al. Oct 1992 A
5164045 Awofeso et al. Nov 1992 A
5178729 Janda Jan 1993 A
5196090 Corbellini et al. Mar 1993 A
5200035 Bhat et al. Apr 1993 A
5227023 Pounder et al. Jul 1993 A
5238534 Manning et al. Aug 1993 A
5260017 Giles Nov 1993 A
5260345 DesMarais et al. Nov 1993 A
5268224 DesMarais et al. Dec 1993 A
5284703 Everhart Feb 1994 A
5300565 Berg et al. Apr 1994 A
5308565 Weber et al. May 1994 A
5310398 Yoneyama May 1994 A
5318554 Young et al. Jun 1994 A
5328935 Van Phan et al. Jul 1994 A
5330822 Berg et al. Jul 1994 A
5331015 DesMarais et al. Jul 1994 A
5338766 Phan et al. Aug 1994 A
5344866 Hall Sep 1994 A
5348453 Baran et al. Sep 1994 A
5350624 Georger Sep 1994 A
5364382 Latimer Nov 1994 A
5369007 Kidwell Nov 1994 A
5372766 Roe Dec 1994 A
5382400 Pike Jan 1995 A
5384179 Roe et al. Jan 1995 A
5387207 Dyer et al. Feb 1995 A
5393379 Parrinello Feb 1995 A
5397316 LaVon et al. Mar 1995 A
5397626 Berg et al. Mar 1995 A
5409572 Kershaw et al. Apr 1995 A
5415640 Kirby May 1995 A
5428076 Roe Jun 1995 A
5434194 Fujimoto et al. Jul 1995 A
5443691 Phan Aug 1995 A
5451452 Phan et al. Sep 1995 A
5458592 Abuto Oct 1995 A
5468437 Hall Nov 1995 A
5506046 Andersen et al. Apr 1996 A
5506277 Griesbach Apr 1996 A
5508072 Andersen et al. Apr 1996 A
5522967 Shet Jun 1996 A
5524759 Herzberg Jun 1996 A
5527300 Sauer Jun 1996 A
5533244 Wadzinski Jul 1996 A
5536264 Hsueh et al. Jul 1996 A
5545450 Andersen et al. Aug 1996 A
5549589 Horney et al. Aug 1996 A
5550167 DesMarais Aug 1996 A
5560878 Dragoo et al. Oct 1996 A
5563179 Stone et al. Oct 1996 A
D375633 Spanagel et al. Nov 1996 S
5571618 Hansen Nov 1996 A
5571849 DesMarais Nov 1996 A
5575874 Griesbach Nov 1996 A
5580624 Andersen et al. Dec 1996 A
5582670 Andersen et al. Dec 1996 A
5585432 Lee et al. Dec 1996 A
5586842 Bae et al. Dec 1996 A
5595628 Gordon Jan 1997 A
5599334 Johnston et al. Feb 1997 A
5601542 Melius Feb 1997 A
5612385 Ceaser et al. Mar 1997 A
D378876 Spanagel et al. Apr 1997 S
5618341 Andersen et al. Apr 1997 A
5624971 Wilson Apr 1997 A
5626857 Thimineur et al. May 1997 A
5631053 Andersen et al. May 1997 A
5632737 Stone et al. May 1997 A
5633291 Dyer et al. May 1997 A
5649409 Gujer et al. Jul 1997 A
5650222 DesMarais et al. Jul 1997 A
D381810 Schultz et al. Aug 1997 S
5658603 Andersen et al. Aug 1997 A
5660900 Andersen et al. Aug 1997 A
5660903 Andersen et al. Aug 1997 A
5660904 Andersen et al. Aug 1997 A
5662731 Andersen et al. Sep 1997 A
5665442 Andersen et al. Sep 1997 A
5667635 Win Sep 1997 A
5672248 Wendt Sep 1997 A
5674917 Wilson Oct 1997 A
5679145 Andersen et al. Oct 1997 A
5679218 Vinson et al. Oct 1997 A
5683772 Andersen et al. Nov 1997 A
5691014 Andersen et al. Nov 1997 A
5692939 DesMarais Dec 1997 A
5693403 Brown et al. Dec 1997 A
5695607 Oriaran et al. Dec 1997 A
5702571 Kamps et al. Dec 1997 A
5705203 Andersen et al. Jan 1998 A
5705238 Andersen et al. Jan 1998 A
5705239 Andersen et al. Jan 1998 A
5705242 Andersen et al. Jan 1998 A
5707474 Andersen et al. Jan 1998 A
5707579 Habelski et al. Jan 1998 A
5709827 Andersen et al. Jan 1998 A
5709913 Andersen et al. Jan 1998 A
D390363 Baum et al. Feb 1998 S
5713881 Rezai et al. Feb 1998 A
5716563 Winterowd et al. Feb 1998 A
5716675 Andersen et al. Feb 1998 A
5719201 Wilson Feb 1998 A
5720851 Reiner Feb 1998 A
5728743 Dyer et al. Mar 1998 A
5736209 Andersen et al. Apr 1998 A
5741581 DesMarais et al. Apr 1998 A
5744506 Goldman et al. Apr 1998 A
5744509 Wilson et al. Apr 1998 A
5753308 Andersen et al. May 1998 A
5753359 Dyer et al. May 1998 A
5763499 DesMarais Jun 1998 A
5770634 Dyer et al. Jun 1998 A
5776388 Andersen et al. Jul 1998 A
5783126 Andersen et al. Jul 1998 A
5785179 Buczwinski Jul 1998 A
5795921 Dyer et al. Aug 1998 A
5800416 Seger et al. Sep 1998 A
5800647 Andersen et al. Sep 1998 A
5810961 Andersen et al. Sep 1998 A
5817703 Blair et al. Oct 1998 A
5830305 Andersen et al. Nov 1998 A
5843055 Seger Dec 1998 A
5843544 Andersen et al. Dec 1998 A
5849155 Gasland Dec 1998 A
5849805 Dyer Dec 1998 A
5851634 Andersen et al. Dec 1998 A
5851648 Stone et al. Dec 1998 A
5853402 Faulks et al. Dec 1998 A
5863958 Dyer et al. Jan 1999 A
5868724 Dierckes et al. Feb 1999 A
5876643 Biggs et al. Mar 1999 A
5879722 Andersen et al. Mar 1999 A
5882479 Oriaran et al. Mar 1999 A
5899893 Dyer et al. May 1999 A
5900114 Brown et al. May 1999 A
5904809 Rokman et al. May 1999 A
5904812 Salman et al. May 1999 A
5908533 Marinack et al. Jun 1999 A
5916503 Rettenbacher Jun 1999 A
5916928 Sessions et al. Jun 1999 A
5919411 Rezai et al. Jul 1999 A
5922780 Dyer et al. Jul 1999 A
5925299 Dierckes et al. Jul 1999 A
5928741 Andersen et al. Jul 1999 A
5948710 Pomplun Sep 1999 A
5948829 Wallajapet et al. Sep 1999 A
5958186 Holm et al. Sep 1999 A
5976235 Andersen et al. Nov 1999 A
5981044 Phan et al. Nov 1999 A
5985434 Qin et al. Nov 1999 A
5994615 Dodge Nov 1999 A
6001218 Hsu et al. Dec 1999 A
6012572 Heathcock Jan 2000 A
6013293 De Moor Jan 2000 A
6013589 DesMarais et al. Jan 2000 A
6017833 Reiner et al. Jan 2000 A
6019871 Rokman et al. Feb 2000 A
6022615 Rettenbacher Feb 2000 A
6027610 Back et al. Feb 2000 A
6030673 Andersen et al. Feb 2000 A
6037282 Milding et al. Mar 2000 A
6043317 Mumick Mar 2000 A
D423232 Reid Apr 2000 S
6051104 Oriaran et al. Apr 2000 A
6054022 Helwig et al. Apr 2000 A
6074527 Hsu et al. Jun 2000 A
6075179 McCormack Jun 2000 A
6077390 Salman et al. Jun 2000 A
6077590 Archer et al. Jun 2000 A
6083211 DesMarais Jul 2000 A
6083586 Andersen et al. Jul 2000 A
6086718 Carter et al. Jul 2000 A
6090195 Andersen et al. Jul 2000 A
6093359 Gauchel et al. Jul 2000 A
6096809 Lorcks et al. Aug 2000 A
6103060 Munerelle et al. Aug 2000 A
6103063 Oriaran et al. Aug 2000 A
6111163 McCormack Aug 2000 A
D430406 Ingalls Sep 2000 S
D430407 Ingalls Sep 2000 S
D430734 Bredendick et al. Sep 2000 S
6113740 Oriaran et al. Sep 2000 A
D431371 Ingalls et al. Oct 2000 S
D431372 Ingalls et al. Oct 2000 S
6129720 Blenke Oct 2000 A
6133193 Kajikawa et al. Oct 2000 A
6136153 Rokman et al. Oct 2000 A
6136873 Hahnle et al. Oct 2000 A
6153053 Harper et al. Nov 2000 A
6160028 Dyer Dec 2000 A
6162961 Tanner et al. Dec 2000 A
6163943 Johansson et al. Dec 2000 A
D436738 Bredendick et al. Jan 2001 S
6168857 Andersen et al. Jan 2001 B1
6174152 Rokman et al. Jan 2001 B1
6174929 Hähnle et al. Jan 2001 B1
D437119 Jahner et al. Feb 2001 S
D437120 Jahner et al. Feb 2001 S
D437489 Jahner et al. Feb 2001 S
D438017 Reid Feb 2001 S
6193838 Oriaran et al. Feb 2001 B1
6200404 Andersen et al. Mar 2001 B1
6200669 Marmon Mar 2001 B1
6203663 Kamps et al. Mar 2001 B1
6207244 Hesch Mar 2001 B1
D440051 Bredendick et al. Apr 2001 S
6214907 Tomka Apr 2001 B1
6224714 Schroeder May 2001 B1
6224977 Kobylivker May 2001 B1
6231960 Dyer et al. May 2001 B1
6231970 Andersen et al. May 2001 B1
6235816 Lorcks et al. May 2001 B1
6238518 Rokman et al. May 2001 B1
D443766 Bredendick et al. Jun 2001 S
6243934 Wadzinski Jun 2001 B1
6245410 Hähnle et al. Jun 2001 B1
6245697 Conrad et al. Jun 2001 B1
6248211 Jennings et al. Jun 2001 B1
6251207 Schultz et al. Jun 2001 B1
6258203 Rokman et al. Jul 2001 B1
6261679 Chen et al. Jul 2001 B1
6274077 Hur et al. Aug 2001 B1
6274667 Shannon Aug 2001 B1
6280570 Harper et al. Aug 2001 B1
6287417 Bhat Sep 2001 B1
6287418 Schroeder Sep 2001 B1
6287422 Harper et al. Sep 2001 B1
6296736 Hsu et al. Oct 2001 B1
6296929 Gentile et al. Oct 2001 B1
6309661 Haynes et al. Oct 2001 B1
6346557 Argy Feb 2002 B1
6355142 Ahrens Mar 2002 B1
6365667 Shannon Apr 2002 B1
6372087 Harper et al. Apr 2002 B2
6376032 Clarke et al. Apr 2002 B1
6383960 Everett May 2002 B1
6387210 Hsu et al. May 2002 B1
6410823 Daley Jun 2002 B1
D459897 Bredendick et al. Jul 2002 S
6413368 Dwiggins et al. Jul 2002 B1
6419790 Leege et al. Jul 2002 B1
6425983 Marinack et al. Jul 2002 B1
6432272 Hollenberg et al. Aug 2002 B1
6436234 Chen et al. Aug 2002 B1
6437214 Everett Aug 2002 B1
6440266 George et al. Aug 2002 B1
6443258 Putt et al. Sep 2002 B1
6444088 Rökman et al. Sep 2002 B2
6447640 Watson et al. Sep 2002 B1
6451166 Marinack et al. Sep 2002 B1
6454904 Hermans Sep 2002 B1
6455600 Hähnle et al. Sep 2002 B1
6462159 Hamada Oct 2002 B1
6472497 Loercks et al. Oct 2002 B2
6500302 Dwiggins et al. Dec 2002 B2
6503372 Rokman et al. Jan 2003 B1
6518479 Graef et al. Feb 2003 B1
6525240 Graef et al. Feb 2003 B1
6527913 Johnson et al. Mar 2003 B1
6531078 Laine et al. Mar 2003 B2
6534149 Daley Mar 2003 B1
6540879 Marinack et al. Apr 2003 B2
6544386 Krzysik et al. Apr 2003 B1
6548132 Clarke et al. Apr 2003 B1
6550634 Alegre De Miquel Apr 2003 B1
6562193 Elonen et al. May 2003 B1
6589634 Schultz et al. Jul 2003 B2
6596389 Hallett et al. Jul 2003 B1
6600086 Mace et al. Jul 2003 B1
6603054 Chen Aug 2003 B2
6612462 Sosalla Sep 2003 B2
6613424 Putt et al. Sep 2003 B1
6616802 Kinsley, Jr. et al. Sep 2003 B1
6617490 Chen Sep 2003 B1
6630054 Graef et al. Oct 2003 B1
6649025 Mills et al. Nov 2003 B2
6657101 Malmgren et al. Dec 2003 B1
6663611 Blaney et al. Dec 2003 B2
6670522 Graef et al. Dec 2003 B1
6673980 Varona et al. Jan 2004 B1
6673983 Graef et al. Jan 2004 B1
6682215 Kinsley, Jr. et al. Jan 2004 B2
6689934 Dodge, II et al. Feb 2004 B2
6703330 Marsh Mar 2004 B1
6706944 Qin et al. Mar 2004 B2
6709548 Marinack et al. Mar 2004 B2
6709550 Holz et al. Mar 2004 B2
6733631 Elonen et al. May 2004 B2
6734335 Graef et al. May 2004 B1
6746570 Burazin et al. Jun 2004 B2
6749719 Burazin et al. Jun 2004 B2
6750262 Hahnle et al. Jun 2004 B1
6752905 Hu Jun 2004 B2
6752907 Edwards et al. Jun 2004 B2
6780356 Putt et al. Aug 2004 B1
6787000 Burazin et al. Sep 2004 B2
6790314 Burazin et al. Sep 2004 B2
6797114 Hu Sep 2004 B2
6808595 Burns Oct 2004 B1
6808790 Chen et al. Oct 2004 B2
6811638 Close Nov 2004 B2
6821385 Burazin et al. Nov 2004 B2
6821387 Hu Nov 2004 B2
6821388 Marsh Nov 2004 B2
6824650 Lindsay et al. Nov 2004 B2
6830656 Kinsley, Jr. Dec 2004 B2
6837956 Cowell et al. Jan 2005 B2
6837972 Marsh Jan 2005 B2
6861477 Wang et al. Mar 2005 B2
6867346 Dopps et al. Mar 2005 B1
6875315 Bakken et al. Apr 2005 B2
6878238 Bakken et al. Apr 2005 B2
6887348 Hermans et al. May 2005 B2
6893535 Hermans et al. May 2005 B2
6921459 Kinsley, Jr. et al. Jul 2005 B2
6939914 Qin et al. Sep 2005 B2
6946058 Hu Sep 2005 B2
6946413 Lange Sep 2005 B2
6951598 Flugge et al. Oct 2005 B2
6956009 Wang et al. Oct 2005 B2
6962645 Graef et al. Nov 2005 B2
6964725 Shannon et al. Nov 2005 B2
6969781 Graef et al. Nov 2005 B2
6983821 Putt et al. Jan 2006 B2
D517816 Dwiggins et al. Mar 2006 S
7028840 Huang Apr 2006 B2
D519739 Schuh et al. May 2006 S
7041196 Lorenz et al. May 2006 B2
7045026 Lorenz et al. May 2006 B2
7052580 Trokhan et al. May 2006 B2
7066006 Minerath, III et al. Jun 2006 B2
7067038 Trokhan et al. Jun 2006 B2
7081559 Fujikawa et al. Jul 2006 B2
7125470 Graef et al. Oct 2006 B2
7141142 Burazin et al. Nov 2006 B2
7155991 Minerath, III et al. Jan 2007 B2
7156954 Farrington, Jr et al. Jan 2007 B2
7160418 Edwards et al. Jan 2007 B2
7166190 Graef et al. Jan 2007 B2
7169451 Clarke et al. Jan 2007 B2
7214293 Trokhan et al. May 2007 B2
7220821 Hähnle et al. May 2007 B2
7229528 Vinson et al. Jun 2007 B2
7235708 Guidotti et al. Jun 2007 B2
D551406 Caruso et al. Sep 2007 S
7285183 Kajander et al. Oct 2007 B2
7287650 Koslow Oct 2007 B2
7291382 Krueger et al. Nov 2007 B2
7294238 Bakken et al. Nov 2007 B2
7300547 Luu et al. Nov 2007 B2
7311800 Russell et al. Dec 2007 B2
7314663 Stelljes, Jr. et al. Jan 2008 B2
7314664 Stelljes, Jr. et al. Jan 2008 B2
7314665 Stelljes, Jr. et al. Jan 2008 B2
7322970 Schmidt et al. Jan 2008 B2
7354502 Polat et al. Apr 2008 B2
7364015 Englert et al. Apr 2008 B2
7374638 Horenziak et al. May 2008 B2
7390378 Carels et al. Jun 2008 B2
7396436 Trokhan et al. Jul 2008 B2
7396584 Azad Jul 2008 B2
7407560 Hilbig et al. Aug 2008 B2
7413629 Fisher et al. Aug 2008 B2
7416636 Blomqvist Aug 2008 B2
7416637 Murray et al. Aug 2008 B2
7435266 Sun et al. Oct 2008 B2
7435313 Boatman et al. Oct 2008 B2
7435316 Boatman et al. Oct 2008 B2
7462754 Malowaniec Dec 2008 B2
7494563 Edwards et al. Feb 2009 B2
7497923 Ward et al. Mar 2009 B2
7497925 Hermans et al. Mar 2009 B2
7497926 Hermans et al. Mar 2009 B2
7503998 Murray et al. Mar 2009 B2
7524399 Hermans et al. Apr 2009 B2
7524404 Boatman et al. Apr 2009 B2
7527152 Lentner May 2009 B2
7543423 Long Jun 2009 B2
7585388 Yeh et al. Sep 2009 B2
7585389 Yeh et al. Sep 2009 B2
7597777 Wilke, II Oct 2009 B2
7601374 Clarke Oct 2009 B2
7629043 Lindsay et al. Dec 2009 B2
7645359 Lorenz et al. Jan 2010 B2
7662257 Edwards et al. Feb 2010 B2
7670457 Murray et al. Mar 2010 B2
7678229 Wilke, II Mar 2010 B2
7682697 Raghavendran et al. Mar 2010 B2
7691228 Edwards et al. Apr 2010 B2
7699959 Ward et al. Apr 2010 B2
7744576 Busam et al. Jun 2010 B2
7750203 Becker et al. Jul 2010 B2
7775958 Mukai et al. Aug 2010 B2
7785696 Boatman et al. Aug 2010 B2
7794565 Shannon et al. Sep 2010 B2
7799161 Schuh et al. Sep 2010 B2
7799968 Chen et al. Sep 2010 B2
7820008 Edwards et al. Oct 2010 B2
7828932 Hermans et al. Nov 2010 B2
7846296 Luu et al. Dec 2010 B2
7850823 Chou et al. Dec 2010 B2
7851057 Englert et al. Dec 2010 B2
7851667 Becker et al. Dec 2010 B2
7857941 Ruthven et al. Dec 2010 B2
7862686 Ward et al. Jan 2011 B2
7887676 Boatman et al. Feb 2011 B2
7918951 Lorenz et al. Apr 2011 B2
7918964 Edwards et al. Apr 2011 B2
7918972 Boatman et al. Apr 2011 B2
7927456 Murray et al. Apr 2011 B2
7935860 Dodge, II May 2011 B2
7938813 Wang May 2011 B2
7972476 Scherb et al. Jul 2011 B2
7994079 Chen et al. Aug 2011 B2
8007640 Boatman et al. Aug 2011 B2
8017827 Hundorf et al. Sep 2011 B2
8029646 Moncla Oct 2011 B2
8056733 Koslow Nov 2011 B2
8083893 Boatman et al. Dec 2011 B2
8092848 Clarke Jan 2012 B2
8102275 McGuire et al. Jan 2012 B2
8110232 Clarke Feb 2012 B2
8123905 Luu et al. Feb 2012 B2
8142612 Murray et al. Mar 2012 B2
8142617 Ruthven et al. Mar 2012 B2
8143472 Bragd et al. Mar 2012 B1
8152957 Edwards et al. Apr 2012 B2
8152958 Super et al. Apr 2012 B2
8158689 Baker et al. Apr 2012 B2
8178025 Awofeso et al. May 2012 B2
8187240 Busam et al. May 2012 B2
8187427 Schuh et al. May 2012 B2
8211078 Noel Jul 2012 B2
8226797 Murray et al. Jul 2012 B2
8257552 Edwards et al. Sep 2012 B2
8293072 Super et al. Oct 2012 B2
8319005 Becker et al. Nov 2012 B2
8324446 Wang et al. Dec 2012 B2
8328985 Edwards et al. Dec 2012 B2
8361278 Fike et al. Jan 2013 B2
8378000 Hintz et al. Feb 2013 B2
8388803 Super et al. Mar 2013 B2
8388804 Super et al. Mar 2013 B2
8394236 Edwards et al. Mar 2013 B2
8398818 Edwards et al. Mar 2013 B2
8398820 Edwards et al. Mar 2013 B2
8425721 Tynkkynen et al. Apr 2013 B2
8435381 Murray et al. May 2013 B2
8461412 Febo et al. Jun 2013 B2
8496637 Hundorf et al. Jul 2013 B2
8512516 Murray et al. Aug 2013 B2
8524040 Edwards et al. Sep 2013 B2
8540846 Miller et al. Sep 2013 B2
8545676 Super et al. Oct 2013 B2
8552252 Hundorf et al. Oct 2013 B2
8562786 Murray et al. Oct 2013 B2
8568559 Murray et al. Oct 2013 B2
8568560 Murray et al. Oct 2013 B2
8603296 Edwards et al. Dec 2013 B2
8632658 Miller et al. Jan 2014 B2
8636874 Super et al. Jan 2014 B2
8647105 Awofeso et al. Feb 2014 B2
8652300 Super et al. Feb 2014 B2
8662344 Gispert Mar 2014 B2
8673115 Edwards et al. Mar 2014 B2
8674170 Busam et al. Mar 2014 B2
8702668 Noel Apr 2014 B2
8741105 Beaupre et al. Jun 2014 B2
8766031 Becker et al. Jul 2014 B2
8778138 Super et al. Jul 2014 B2
8791318 Becker et al. Jul 2014 B2
8815056 Araki et al. Aug 2014 B2
8829263 Haggstrom et al. Sep 2014 B2
8841506 Febo et al. Sep 2014 B2
8852397 Super et al. Oct 2014 B2
8864944 Miller et al. Oct 2014 B2
8864945 Miller et al. Oct 2014 B2
8911592 Edwards et al. Dec 2014 B2
8968516 Super et al. Mar 2015 B2
8979815 Roe et al. Mar 2015 B2
8980052 Super et al. Mar 2015 B2
9017517 Super et al. Apr 2015 B2
9044359 Wciorka et al. Jun 2015 B2
9051691 Miller et al. Jun 2015 B2
9057158 Miller et al. Jun 2015 B2
9138360 Febo et al. Sep 2015 B1
9144524 Febo et al. Sep 2015 B2
9216116 Roe et al. Dec 2015 B2
9216118 Roe et al. Dec 2015 B2
9228048 Wibaux et al. Jan 2016 B2
9241845 Hundorf et al. Jan 2016 B2
9243367 Rekoske et al. Jan 2016 B2
9267240 Lee et al. Feb 2016 B2
9279219 Edwards et al. Mar 2016 B2
9309627 Miller et al. Apr 2016 B2
9326896 Schäfer et al. May 2016 B2
9333120 Lavon et al. May 2016 B2
9334610 Kinnunen et al. May 2016 B2
9340363 Jackels et al. May 2016 B2
9365977 Beaupre et al. Jun 2016 B2
9371614 Schuh et al. Jun 2016 B2
9371615 Super et al. Jun 2016 B2
9375358 Ehrnsperger et al. Jun 2016 B2
9382665 Miller et al. Jul 2016 B2
9388534 Super et al. Jul 2016 B2
9447543 Matula Sep 2016 B2
9468566 Rosati et al. Oct 2016 B2
9476162 Lee et al. Oct 2016 B2
9492328 Jackels et al. Nov 2016 B2
9493911 Miller et al. Nov 2016 B2
9532910 Rosati et al. Jan 2017 B2
9572728 Ashton et al. Feb 2017 B2
9579238 Noel Feb 2017 B2
9603755 Tanaka Mar 2017 B2
9649232 Hippe et al. May 2017 B2
9649830 Rasch May 2017 B2
9657443 Rekoske et al. May 2017 B2
9662246 Collinson et al. May 2017 B2
9668926 Jackels et al. Jun 2017 B2
9708774 Lee et al. Jul 2017 B2
9713556 Arizti et al. Jul 2017 B2
9713557 Arizti et al. Jul 2017 B2
9739015 Miller et al. Aug 2017 B2
9744755 Thompson, Jr. et al. Aug 2017 B2
9752280 Matula Sep 2017 B2
9763835 Becker et al. Sep 2017 B2
9789009 Joseph Oct 2017 B2
9789011 Roe et al. Oct 2017 B2
9808554 Swaniker Nov 2017 B2
9822487 Ahoniemi et al. Nov 2017 B2
9877872 Mumby et al. Jan 2018 B2
9879382 Miller et al. Jan 2018 B2
9950309 Lee et al. Apr 2018 B2
9963568 Nakatsuji et al. May 2018 B2
9974697 Lavon et al. May 2018 B2
9974699 Kreuzer et al. May 2018 B2
9987176 Roe et al. Jun 2018 B2
9988763 Ramaratnam et al. Jun 2018 B2
9994712 Cai et al. Jun 2018 B2
9995005 Ramaratnam et al. Jun 2018 B2
10004647 Jackels et al. Jun 2018 B2
10022280 Ehmsperger et al. Jul 2018 B2
10034800 Febo et al. Jul 2018 B2
10039673 Mumby et al. Aug 2018 B2
10039676 LaVon Aug 2018 B2
10052242 Bianchi et al. Aug 2018 B2
10065175 Lee et al. Sep 2018 B2
10071002 Bianchi et al. Sep 2018 B2
10076449 Allen et al. Sep 2018 B2
10099425 Miller, IV et al. Oct 2018 B2
10130519 Mumby et al. Nov 2018 B2
10130525 Rosati et al. Nov 2018 B2
10130527 Peri et al. Nov 2018 B2
10137039 Stelzig et al. Nov 2018 B2
10138600 Jannari et al. Nov 2018 B2
10149788 Kreuzer et al. Dec 2018 B2
10190263 Ramaratnam et al. Jan 2019 B2
10196780 Lee et al. Feb 2019 B2
10201644 Haggstrom et al. Feb 2019 B2
10208426 Sealey et al. Feb 2019 B2
10221350 Shalagina et al. Mar 2019 B2
10231874 Mumby et al. Mar 2019 B2
10245188 Jackels et al. Apr 2019 B2
10247195 Manninen et al. Apr 2019 B2
10259151 Kiiskinen et al. Apr 2019 B2
10273635 Miller, IV et al. Apr 2019 B2
10292875 Tapp et al. May 2019 B2
10301775 Nordström et al. May 2019 B2
10301779 Sealey, II et al. May 2019 B2
10322040 Stiehl et al. Jun 2019 B2
10335324 Roe et al. Jul 2019 B2
10619303 Thole et al. Apr 2020 B2
11015292 Venema et al. May 2021 B2
11136700 Venema et al. Oct 2021 B2
20010013389 Fingal et al. Aug 2001 A1
20020007169 Graef et al. Jan 2002 A1
20020013560 Erspamer et al. Jan 2002 A1
20020055310 Falk et al. May 2002 A1
20020088581 Graef et al. Jul 2002 A1
20020092634 Rokman et al. Jul 2002 A1
20020132121 Palacio et al. Sep 2002 A1
20020183703 Singh Dec 2002 A1
20030018311 Graef Jan 2003 A1
20030106656 Johnson et al. Jun 2003 A1
20030139715 Dodge et al. Jul 2003 A1
20030167045 Graef et al. Sep 2003 A1
20030171727 Graef et al. Sep 2003 A1
20030220039 Chen et al. Nov 2003 A1
20040045685 Horner et al. Mar 2004 A1
20040063367 Dodge et al. Apr 2004 A1
20040065420 Graef et al. Apr 2004 A1
20040084162 Shannon et al. May 2004 A1
20040084164 Shannon et al. May 2004 A1
20040096642 Maruyama et al. May 2004 A1
20040110017 Lonsky et al. Jun 2004 A1
20040111817 Chen et al. Jun 2004 A1
20040112783 Mukai et al. Jun 2004 A1
20040115419 Qin et al. Jun 2004 A1
20040115451 Lonsky et al. Jun 2004 A1
20040121680 Yahiaoui et al. Jun 2004 A1
20040127873 Varona et al. Jul 2004 A1
20040142620 Kinsley Jul 2004 A1
20040157524 Polat et al. Aug 2004 A1
20040192136 Gusky Sep 2004 A1
20040254551 Carnes et al. Dec 2004 A1
20040256066 Lindsay et al. Dec 2004 A1
20050034826 Hu Feb 2005 A1
20050060933 Henson Mar 2005 A1
20050090789 Graef et al. Apr 2005 A1
20050095980 Chang May 2005 A1
20050124709 Krueger et al. Jun 2005 A1
20050136772 Chen et al. Jun 2005 A1
20050142348 Kajander et al. Jun 2005 A1
20050152954 Farrell et al. Jul 2005 A1
20050211718 Decker Sep 2005 A1
20050230069 Hilbig et al. Oct 2005 A1
20050244627 Travelute et al. Nov 2005 A1
20050245393 Herfert Nov 2005 A1
20050247397 Kraus et al. Nov 2005 A1
20050247416 Forry et al. Nov 2005 A1
20050267226 Wehr et al. Dec 2005 A1
20060005916 Stelljes et al. Jan 2006 A1
20060008621 Gusky Jan 2006 A1
20060011315 Kinsley et al. Jan 2006 A1
20060030632 Krueger et al. Feb 2006 A1
20060081348 Graef et al. Apr 2006 A1
20060135026 Arendt et al. Jun 2006 A1
20060142719 Vogt et al. Jun 2006 A1
20060191357 Minerath et al. Aug 2006 A1
20060246272 Zhang et al. Nov 2006 A1
20060266485 Knox et al. Nov 2006 A1
20060266487 Scherb et al. Nov 2006 A1
20070148433 Mallory et al. Jun 2007 A1
20070179210 Swaniker Aug 2007 A1
20070218485 Davis et al. Sep 2007 A1
20070235466 Fulscher Oct 2007 A1
20070269644 Harper et al. Nov 2007 A1
20080052859 Orlandi Mar 2008 A1
20080121461 Gross et al. May 2008 A1
20080179775 Palm et al. Jul 2008 A1
20080312617 Hundorf et al. Dec 2008 A1
20080312618 Hundorf et al. Dec 2008 A1
20080312619 Ashton et al. Dec 2008 A1
20080312620 Ashton et al. Dec 2008 A1
20080312621 Hundorf et al. Dec 2008 A1
20080312622 Hundorf et al. Dec 2008 A1
20080312625 Hundorf et al. Dec 2008 A1
20080312628 Hundorf et al. Dec 2008 A1
20090000753 Vestola et al. Jan 2009 A1
20090001635 Newson et al. Jan 2009 A1
20090008275 Ferrari et al. Jan 2009 A1
20090117365 Mallory et al. May 2009 A1
20090131898 Malmgren et al. May 2009 A1
20090205794 Scherb et al. Aug 2009 A1
20090270005 Takahashi et al. Oct 2009 A1
20100075858 Davis et al. Mar 2010 A1
20100132144 Rautray Jun 2010 A1
20100136294 Manifold et al. Jun 2010 A1
20100155284 Gerstle Jun 2010 A1
20100251611 Henson Oct 2010 A1
20100273716 Harris Oct 2010 A1
20100327484 Schuh et al. Dec 2010 A1
20110151596 Cho Jun 2011 A1
20110290437 Vogel Dec 2011 A1
20120121674 Pedoja May 2012 A1
20140001196 Bushman Jan 2014 A1
20140009606 Puccio Jan 2014 A1
20140102650 Qin et al. Apr 2014 A1
20140121623 Kirby May 2014 A1
20140158626 Ziemer et al. Jun 2014 A1
20140189970 Fingal et al. Jul 2014 A1
20140231037 Beaupre et al. Aug 2014 A1
20140324007 Hundorf et al. Oct 2014 A1
20150096700 Heiskanen Apr 2015 A1
20150099086 Kim Apr 2015 A1
20150114581 Kinnunen Apr 2015 A1
20150118466 Zwick Apr 2015 A1
20150144829 Grünbauer May 2015 A1
20150176221 Maladen Jun 2015 A1
20150284911 Juvonen et al. Oct 2015 A1
20160219810 Erkkilä et al. Aug 2016 A1
20160353820 Baychar Dec 2016 A1
20170335521 Lee Nov 2017 A1
20170335522 Heiskanen et al. Nov 2017 A1
20170362775 Juvonen et al. Dec 2017 A1
20180119353 Tolfsson et al. May 2018 A1
20180327973 Siitonen et al. Nov 2018 A1
20180355527 Strandqvist et al. Dec 2018 A1
20190161915 Swails et al. May 2019 A1
Foreign Referenced Citations (192)
Number Date Country
517303 Dec 2016 AT
519414 Jun 2018 AT
519423 Aug 2018 AT
281485 Feb 1965 AU
1973057198 Jan 1975 AU
700394 Jan 1999 AU
721197 Jun 2000 AU
2002300959 Jun 2003 AU
2001285005 Feb 2006 AU
2007272602 Jan 2008 AU
2012298266 Jun 2016 AU
436451 Sep 1939 BE
949706 Jun 1974 CA
979699 Dec 1975 CA
2194176 Dec 1996 CA
2868935 Sep 2014 CA
2998561 Mar 2018 CA
1173122 Feb 1998 CN
1260977 Jul 2000 CN
1270648 Oct 2000 CN
1364182 Aug 2002 CN
1094542 Nov 2002 CN
1518423 Aug 2004 CN
1555431 Dec 2004 CN
101410078 Feb 2014 CN
103993498 Mar 2016 CN
105828763 Aug 2016 CN
105828764 Aug 2016 CN
105899173 Aug 2016 CN
104302834 Nov 2016 CN
106456416 Feb 2017 CN
107460764 Dec 2017 CN
107988838 May 2018 CN
109937027 Jun 2019 CN
2041406 Apr 1971 DE
2438587 Mar 1975 DE
2902255 Jul 1980 DE
3307736 Sep 1984 DE
3420195 Jun 1987 DE
4207233 Nov 1993 DE
0101319 Mar 1984 EP
0049944 Nov 1984 EP
0136329 Jan 1989 EP
0158938 Dec 1989 EP
0296242 Jul 1991 EP
0443082 Aug 1991 EP
0242361 Sep 1991 EP
0512819 Nov 1992 EP
0150777 Nov 1994 EP
0481745 Jul 1996 EP
0537005 Jul 1997 EP
0671504 Aug 1997 EP
0742858 Jun 1999 EP
1007784 Feb 2003 EP
1145695 Jan 2004 EP
1194644 Mar 2004 EP
1400224 Mar 2006 EP
1384457 May 2006 EP
1808116 Jul 2007 EP
1649094 Sep 2007 EP
1442173 Mar 2008 EP
1583865 May 2008 EP
1463432 Aug 2008 EP
1576233 Oct 2008 EP
1813237 Dec 2008 EP
1932968 Sep 2009 EP
1967626 Sep 2009 EP
1666240 Mar 2011 EP
1440195 Aug 2011 EP
1812637 Jan 2012 EP
1950343 Apr 2012 EP
1456472 May 2012 EP
1497489 Aug 2012 EP
1808152 Aug 2012 EP
1567718 Apr 2013 EP
2599915 Jun 2013 EP
1268937 Feb 2014 EP
2540892 Apr 2014 EP
1876291 Sep 2014 EP
2843130 Mar 2015 EP
2952164 Dec 2015 EP
2952165 Dec 2015 EP
2737131 Jan 2016 EP
1916333 Jun 2016 EP
2001662 Jun 2016 EP
1380401 Jul 2016 EP
2807212 Apr 2017 EP
2940210 Aug 2017 EP
2622132 Apr 2018 EP
3327395 May 2018 EP
3162956 Mar 2019 EP
3108060 Apr 2021 EP
385106 Mar 1973 ES
8606100 Apr 1986 ES
2362723 Jul 2011 ES
812601 Feb 1982 FI
843904 Oct 1984 FI
83741 Dec 1992 FI
112812 Jan 2004 FI
127377 Apr 2018 FI
128917 Mar 2021 FI
873763 Jul 1942 FR
1449737 Aug 1966 FR
1528992 Jun 1968 FR
2206398 Sep 1976 FR
1145484 Mar 1969 GB
2109023 May 1983 GB
2136813 Sep 1984 GB
2116882 Oct 1985 GB
1182DEL2005 Jan 2007 IN
231170 Mar 2009 IN
2957KOLNP2014 May 2015 IN
3108MUM2014 Apr 2016 IN
283291 May 2017 IN
201717030330 Dec 2017 IN
201837033267 Oct 2018 IN
1983115199 Jul 1983 JP
1989501859 Jun 1989 JP
1993140886 Jun 1993 JP
2010215872 Sep 2010 JP
2014037652 Feb 2014 JP
1020040088545 Oct 2004 KR
100450272 Dec 2005 KR
100637646 Oct 2006 KR
100685522 Feb 2007 KR
100725240 Jun 2007 KR
1020100112299 Oct 2010 KR
1020130077856 Jul 2013 KR
101386319 Apr 2014 KR
1020180007337 Jan 2018 KR
2393093 Jun 2010 RU
7304825 Nov 1977 SE
7304888 Nov 1977 SE
412881 Mar 1980 SE
1651412 Apr 2018 SE
540719 Oct 2018 SE
1986003505 Jun 1986 WO
1991010416 Jul 1991 WO
1992003283 Mar 1992 WO
1996031652 Oct 1996 WO
9637138 Nov 1996 WO
9824621 Jun 1998 WO
2000001882 Jan 2000 WO
2000050694 Aug 2000 WO
0112902 Feb 2001 WO
2001068793 Sep 2001 WO
2001083866 Nov 2001 WO
02055788 Jul 2002 WO
2002055788 Jul 2002 WO
2003069038 Aug 2003 WO
2004025009 Mar 2004 WO
2004112956 Dec 2004 WO
2005060712 Jul 2005 WO
2006052967 May 2006 WO
2006094077 Sep 2006 WO
2007074625 Jul 2007 WO
07110497 Oct 2007 WO
08027488 Mar 2008 WO
2009006371 Jan 2009 WO
2009060118 May 2009 WO
2011104427 Sep 2011 WO
12006714 Jan 2012 WO
14080084 May 2014 WO
2014068196 May 2014 WO
2014080084 May 2014 WO
14202841 Dec 2014 WO
2014205048 Dec 2014 WO
15036659 Mar 2015 WO
15066036 May 2015 WO
15080726 Jun 2015 WO
2015083092 Jun 2015 WO
2015112155 Jul 2015 WO
2015173474 Nov 2015 WO
2016050901 Apr 2016 WO
2016051350 Apr 2016 WO
2016185398 Nov 2016 WO
2016200299 Dec 2016 WO
2017006216 Jan 2017 WO
2017006241 Jan 2017 WO
2017046751 Mar 2017 WO
17079169 May 2017 WO
17079310 May 2017 WO
2017079169 May 2017 WO
2017137879 Aug 2017 WO
2018002815 Jan 2018 WO
2018011667 Jan 2018 WO
2018041355 Mar 2018 WO
2018065668 Apr 2018 WO
2018116223 Jun 2018 WO
2018152082 Aug 2018 WO
2018171913 Sep 2018 WO
2018171914 Sep 2018 WO
Non-Patent Literature Citations (1)
Entry
Copending U.S. Appl. No. 15/773,438, filed May 3, 2018, by Qin et al. for “Foamed Composite Web With Low Wet Collapse”.
Related Publications (1)
Number Date Country
20180320318 A1 Nov 2018 US
Provisional Applications (1)
Number Date Country
62250242 Nov 2015 US